A role for HSC70 in regulating antigen trafficking and presentation during macronutrient deprivation by Deffit, Sarah N.
  
 
 
 
A ROLE FOR HSC70 IN REGULATING ANTIGEN TRAFFICKING AND 
PRESENTATION DURING MACRONUTRIENT DEPRIVATION 
 
 
  
 
 
 
Sarah N. Deffit 
 
 
 
 
 
 
 
 
 
Submitted to the faculty of the University Graduate School 
in partial fulfillment of the requirements 
for the degree 
Doctor of Philosophy 
in the Department of Microbiology and Immunology, 
Indiana University 
 
February 2015 
  
ii 
 
 
Accepted by the Graduate Faculty, of Indiana University, in partial 
fulfillment of the requirements for the degree of Doctor of Philosophy. 
 
 
 
 
 
                                                         
     Janice S. Blum, Ph.D., Chair 
 
Doctoral Committee 
 
                                                         
     Mark H. Kaplan, Ph.D. 
 
 
 
                                                         
     Margaret E. Bauer, Ph.D. 
 
December 15, 2014 
 
                                                         
    Xiao-Ming Yin, M.D., Ph.D 
 
 
 
 
 
       
  
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2014 
Sarah N. Deffit  
  
iv 
 
Acknowledgements 
 
I would like to first thank Dr. Janice Blum for all her support and guidance. As a 
mentor, Dr. Blum has been instrumental not only by enhancing my growth as a 
scientist but also in shaping my career development. Her encouragement and 
advice in science as well as personally has changed my life for the better. 
 
I would like to thank my committee, Drs. Bauer, Kaplan, and Yin, for their 
leadership throughout my graduate career as well as the Sullivan Laboratory for 
all their support with experiments. I would also like to thank Janis, Cindy, Cathy 
and other members in the department for their help and assistance. 
  
A big thank you to present and past Blum lab members: Lynette, Victoria, 
Crystal, Lilliana, Gail, and Shawna. Aside from making the Blum lab such an 
enjoyable working environment, their help with technical problems as well as 
academic discussions have been indispensable. 
  
Finally, I would like to thank my family. My husband, who moved half way across 
the country for me, not once but twice, has been so supportive of my studies. My 
parents have also been important supporters, always encouraging me to pursue 
my aspirations. 
  
v 
 
Sarah N. Deffit 
 
A ROLE FOR HSC70 IN REGULATING ANTIGEN TRAFFICKING AND 
PRESENTATION DURING MACRONUTRIENT DEPRIVATION 
 
Globally, protein malnutrition remains problematic, adversely affecting several 
systems including the immune system. Although poorly understood, protein 
restriction severely disrupts host immunity and responses to infection. Induction 
of high-affinity, long-lasting immunity depends upon interactions between B and 
T lymphocytes. B lymphocytes exploit several pathways including endocytosis, 
macroautophagy, and chaperone-mediated autophagy to capture and deliver 
antigens to the endosomal network. Within the endosomal network antigens are 
processed and loaded onto major histocompatibility complex (MHC) class II 
molecules for display and recognition by T lymphocytes. To examine the effect of 
macronutrient malnutrition on MHC class II antigen presentation, we grew B 
lymphocytes in media containing amino acids, sugars and vitamins but lacking 
serum, which contains several types of macronutrients. Our studies show 
macronutrient stress amplified macroautophagy, favoring MHC class II 
presentation of cytoplasmic antigens targeted to autophagosomes. By contrast, 
macronutrient stress diminished MHC class II presentation of membrane 
antigens including the B cell receptor (BCR) and cytoplasmic proteins that utilize 
the chaperone-mediated autophagy pathway. The BCR plays a critical role in 
MHC class II antigen presentation, as it captures exogenous antigens leading to 
internalization and degradation within the endosomal network. While intracellular 
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protease activity increased with macronutrient stress, endocytic trafficking and 
proteolytic turnover of the BCR was impaired. Addition of high molecular mass 
macronutrients restored endocytosis and antigen presentation, evidence of tightly 
regulated membrane trafficking dependent on macronutrient status. Cytosolic 
chaperone HSC70 has been shown to play a role in endocytosis, 
macroautophagy, chaperone-mediated autophagy and proteolysis by the 
proteasome, potentially connecting distinct routes of antigen presentation. Here, 
altering the abundance of HSC70 was sufficient to overcome the inhibitory 
effects of nutritional stress on BCR trafficking and antigen presentation 
suggesting macronutrient deprivation alters the availability of HSC70. Together, 
these results reveal a key role for macronutrient sensing in regulating immune 
recognition and the importance of HSC70 in modulating distinct membrane 
trafficking pathways during cellular stress. These results offer a new explanation 
for impaired immune responses in protein malnourished individuals. 
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Introduction 
 
The immune system  
The human body is under constantly exposed to pathogens and commensal 
microbes, which utilize nutrients to further their survival. The immune system has 
evolved to defend against these pathogens. The immune system can be divided 
into two main branches, the innate and the adaptive immune responses. The 
innate immune response occurs rapidly and is rather non-specific, recognizing 
generic molecular patterns associated with pathogens. This rapid response is 
critical for initial suppression and containment of an infection and for recruiting 
immune cells to the infection; however, this response does not lead to the 
development of long-lasting, protective immunity. The adaptive immune response 
is slower to develop but is highly specific and leads to long lasting immunity 
through the production of memory cells.  
 
The immune system is dependent on the ability of cells to distinguish foreign 
pathogens from self. Both the innate and adaptive immune responses depend on 
specific receptors to recognize foreign pathogens or invaders. Innate immune 
receptors on human cells can recognize pathogen-associated molecular 
patterns. The adaptive immune system relies on antigen (Ag) presentation, a 
process by which cells display or present peptides derived from processed 
protein Ags bound to receptor-like major histocompatibility complex (MHC) 
molecules. MHC molecules are constantly presenting peptides on the cell 
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surface, with the majority of these peptides derived from self-proteins. These 
MHC:peptide complexes act as a biosensor, as changes in the peptides 
presented during infection or disease results in activation or tolerance of the 
adaptive immune response. There are two classes of MHC molecules: MHC 
class I, which are present on all nucleated cells, and MHC class II, which are 
present on specialized immune cells.  
 
MHC class II antigen presentation pathway 
MHC class II molecules are heterodimers composed of α and β subunits. The 
HLA-DR, -DQ, and -DP loci encode the human class II α and β subunits (1). 
MHC class II molecules are detected at high levels on professional Ag presenting 
cells (APCs): dendritic cells, B cells, and macrophages as well as some 
endothelial, epithelial and tumor cells (2, 3). MHC class II molecules fold in the 
endoplasmic reticulum (ER) and are trafficked to the endosomal/lysosomal 
network where they bind to processed protein Ags. Once bound to processed 
peptides, MHC class II molecules are shuttled to the cell surface to interact with 
CD4+ T cells (Figure 1). T cell receptors and accessory molecules on CD4+ T 
cells recognize the specific MHC class II:peptide complex and co-stimulatory 
molecules on APCs. Upon this recognition, CD4+ T cells are activated, secreting 
cytokines and initiating an immune response.  
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Classically, MHC class II molecules present exogenous Ags that have been 
engulfed and processed through the endosomal network (4). Within the 
endosomal network pH dependent proteases, including cathepsins, play critical 
Figure 1. MHC class II antigen presentation pathway. Exogenous Ags 
are internalized via clathrin-mediated endocytosis and delivered to the 
endosomal/lysosomal network. Endogenous Ags can be delivered by 
autophagy pathways such as macroautophagy (MA) and chaperone-
mediated autophagy (CMA). Once delivered into the endosomal/lysosomal 
network, acidic proteases within these compartments process the Ag into 
small peptides. MHC class II molecules assemble and associate with the 
chaperone invariant chain in the ER. These complexes are sorted through 
the Golgi and into the endosomal/lysosomal network. Lysosomal acidic 
proteases sequentially cleave invariant chain, leaving the invariant chain 
fragment CLIP in the MHC class II peptide binding groove. HLA-DM 
catalyzes the removal of CLIP and MHC class II binding of antigenic 
peptides. MHC class II:peptide complexes are shuttled to the surface to be 
displayed for recognition by CD4+ T cells 
MHC class II Invariant Chain HLA-DM Antigen 
Lysosome 
 
 
 
Golgi 
E.R. 
CD4+%T%cell%
HSC70 
CMA 
MA 
T%Cell%Receptor%
Endocytosis 
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roles in Ag processing and the formation of short (9-25 amino acids) peptides 
capable of binding MHC class II molecules (5). MHC class II molecules can also 
present peptides derived from self-proteins that gain access to the lysosomal 
network. Membrane proteins can gain access to endosomes and lysosomes 
while being shuttled to the surface or when endocytosed. While a majority of the 
peptides presented by MHC class II molecules follow this classical pathway, 
roughly 10-30% of the peptides bound to MHC class II are derived from nuclear 
or cytoplasmic Ags, including viral and tumor Ags (4, 6-8). Cytoplasmic and 
nuclear Ags gain access to the endosomal network through autophagy pathways 
including the macroautophagy (MA) and chaperone-mediated autophagy (CMA) 
pathways (Figure 1) (9). These Ags may be processed by cytoplasmic enzymes 
such as the proteasome and calpains as well as by enzymes within endosomal 
compartments (10, 11). Activation of CD4+ T cells in response to MHC class II 
presentation of membrane, cytoplasmic and nuclear Ags results in effective 
immune responses to intracellular pathogens, tumors and the development of 
autoimmune diseases.  
 
Key players in MHC class II antigen presentation 
Invariant chain 
MHC class II molecules assemble in the ER where they bind invariant (Ii) chain 
(12). Ii chain stabilizes the MHC class II heterodimer, prevents premature loading 
of peptides in the ER, and directs the trafficking of MHC class II molecules 
through the Golgi and into the endosomal network (13-15). Ii chain is 
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systematically cleaved by acidic proteases generating degradative intermediates 
LIP, SLIP and CLIP: the latter fragment of Ii chain is bound to the MHC class II 
binding groove (Figure 2) (12, 16-21). The first cleavage of Ii is mediated by 
aspartyl cathepsin proteases to yield the fragment known as LIP.  After the intial 
cleavage, cathepsins S and L mediate the final two cleavages yielding the 
fragments SLIP and finally CLIP (21, 22). 
 
 
 
Ii chain is critical for MHC class II presentation of both exogenous and 
endogenous Ag. The level of Ii chain expression is inversely correlated with the 
amount of exogenous Ag required to activate T cells (23). Furthermore, APCs 
from Ii chain knockout mice have a reduced capacity to present exogenous Ag to 
Figure 2. Invariant chain degradation.  
Ii chain is sequentially degraded by acidic proteases upon its delivery with MHC class 
II to the endosomal/lysosomal network.  The degradative intermediates LIP (22 kDa) 
and SLIP (10 kDa) accumulate upon inhibition of cathepsin (Cat) S and L activity by 
the pharmacological leupeptin allowing detection of these fragments by immunoblot 
analysis (J. Lich, 2000). 
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T cells (24). In contrast, MHC class II presentation of endogenous Ags is 
enhanced by low Ii chain levels. For example, the cytosolic influenza virus matrix 
protein was presented by MHC class II molecules in Ii chain deficient cells, but 
inhibited in cells expressing Ii chain (25). These studies as well as studies in 
mice show alterations in Ii chain expression can modify the MHC class II Ag 
presentation pathway (26). 
 
HLA-DM and -DO 
HLA-DM (DM), a nonclassical MHC class II protein, catalyzes the removal of the 
Ii chain fragment CLIP and further edits peptides that bind MHC class II favoring 
association with high affinity peptides within the ligand binding groove (19, 27, 
28). DM is a non-polymorphic heterodimer composed of DMα and DMβ (29). DM 
localizes to late endosomes where it associates with MHC class II molecules to 
remove the CLIP fragment of Ii chain or other low affinity, loosely bound peptides 
(30). As DM is essential in removal of CLIP fragment, the majority of surface 
MHC class II on APCs from DM-deficient mice are loaded with CLIP (31). 
 
B cells and to a lesser extent dendritic cells, express another nonclassical class II 
protein, HLA-DO (DO). DO also consists of a heterodimer, composed of DOα 
and DOβ and resides only in endosomal compartments. DO has been shown to 
inhibit the function of DM, though there has been some controversy regarding 
this observation with alternate claims that DO enhanced DM function (32-34). 
Recent studies suggest DO binds in a competitive fashion to the same region of 
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DM as MHC class II molecules (35). Initial studies on DO indicated the 
interaction between DO and DM may be pH dependent with dissociation at low 
pH, however a recent structural analysis argues against this pH dependence in 
DM and DO association (36, 37). 
 
Lysosomal proteases 
Proteases found within lysosomes and endosomes are critical components of the 
MHC class II pathway. These proteases are required for Ii chain processing as 
well as degradation of protein Ags into smaller peptides that can be loaded in the 
ligand binding groove of MHC class II molecules. Cathepsins are a family of 
acidic proteases within lysosomes and endosomes that have been shown to play 
critical roles in the MHC class II pathway.  Cathepsins B, C, D, X, H, L, and S as 
well as asparagine endopeptidase (AEP) have been shown to be involved in 
immune responses (38). Several proteases are involved in Ii chain processing 
including AEP and cathepsin L, S, H, and F (39-41). Furthermore, several 
cathepsins including cathepsin B and D have been shown to play a role in Ag 
degradation (42).  
 
Cathepsin S and L are cysteine endopeptidases exhibiting important non-
redundant roles in Ag presentation (43, 44). Cathepsin S has been shown to play 
a critical role in B cells, as well as dendritic cells, where this enzyme is required 
for complete proteolysis of Ii chain affecting MHC class II trafficking and peptide 
loading (21, 42). Cells deficient in cathepsin S have a reduced capacity to 
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present certain epitopes suggesting this enzyme is vital in the processing of 
specific Ags (5, 43). Cathepsin S preferentially cleaves peptides N-terminal to 
Val-Val-Arg motifs, while cathepsin L prefers a very similar motif, 
hydrophobic/aromatic amino acid-Phe-Arg. Cathepsin L is expressed in thymic 
epithelial cells and to a lesser extent in professional APCs. In thymic epithelial 
cells, cathepsin L is responsible for Ii chain degradation, with loss of cathepsin L 
in these cells disrupting positive selection of T cells in the thymus (45). Similar to 
cathepsin S, cathepsin L-deficient cells exhibit reduced presentation of antigenic 
epitopes suggesting that individual cathepsins can shape Ag processing and host 
T cell responses (5). Cathepsin B is another cysteine peptidase with 
carboxypeptidase as well as endopeptidase activity (46). Like cathepsins S and 
L, cathepsin B is involved in MHC class II Ag presentation, influencing both Ii 
chain degradation and Ag processing (11, 47, 48). Inhibiting cathepsin B activity 
in B cells impairs MHC class II presentation of epitopes derived from 
endogenous and exogenous Ags (11). In some cases these proteases appear to 
have redundant roles in Ag processing (49, 50). 
 
Cytosolic proteases 
Cytosolic Ags can be processed by proteases within the cytoplasm prior to 
transport into MHC class II rich lysosomal/endosomal compartments. The 
proteasome as well as cytosolic calpains have been shown to play a critical role 
in the processing of cytosolic Ags for MHC class II presentation (11, 51).  
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The proteasome contains multiple catalytic subunits: the 20S core as well as the 
19S and PA28 subunits, which together form the 26S proteasome (52).  The 
proteasome mediates five distinct cleavages: chymotrypsin-like activity where the 
enzymatic subunits cleave on the carboxylic side of large hydrophobic residues, 
trypsin-like activity in which the enzymes cleave at or near basic residues, and 
additional specificities for cleavage sites around acidic, branched and small 
neutral amino acids (53).  
 
Protein substrates can be preferentially targeted for proteasomal degradation 
following their ubiquitination. Ubiquitination generally occurs at specifc lysine 
residues within a protein and can impact a protein’s fate. Addition of subsequent 
ubiquitins on lysine residues within a ubiquitin adduct, leads to the formation of 
extended polyubiquitinated chains. Chains of more than 4 ubiquitins, branching 
from lysine 48 (K48) of the initial ubiquitin protein conjugate, targets proteins for 
destruction by the proteasome (54). However, some proteins including 
ovalbumin, are targeted to the proteasome in an ubiquitin-independent manner 
(55). In these latter cases, the mechanisms that regulate the degradation of 
these proteins are not well understood. 
 
B cell receptor 
B cells are unique in their expression of immunoglobulin (Ig) molecules. Ig is 
composed of two heavy and two light chains. There are two loci that express Ig 
light chain, Ig λ and Ig κ (56).  During B cell development, the Ig genes undergo 
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rearrangement that leads to the expression of one heavy chain rearrangement 
and one light chain rearrangement that will pair to form the unique Ig protein (57). 
RNA splicing regulates whether Ig is secreted in the form of Ab or membrane-
bound (58, 59). When membrane-bound, Ig associates with signaling proteins 
including Igα and Igβ; this is termed the B cell-receptor (BCR) (Figure 3) (60).  
 
 
 
The BCR acts as a signaling molecule as well as a receptor to internalize 
exogenous Ags. When bound and crosslinked by Ag, the BCR associated Igα 
and Igβ subunits transmit signals to activate the B cell (61). Surface BCR, 
whether bound to Ag or not, is constitutively internalized and delivered into 
endosomes and lysosomes for proteolytic processing by cathepsins to yield 
Figure 3. The B cell receptor (BCR). B cells express immunoglobulin (Ig) which 
is composed of two heavy and two light chains that fold in the ER. In its membrane 
bound form, Ig associates with signaling molecules Igα and Igβ on the plasma 
membrane forming the B Cell Receptor (BCR). Surface BCR, alone or complexed 
with antigen, is constitutively internalized into endosomes. Here, cathepsins digest 
the BCR and antigens yielding peptides for presentation by MHC class II 
molecules.  
Plasma&
Membrane&
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peptides for presentation by MHC class II molecules (62-65). Trafficking of the 
BCR:Ag complex to endosomal compartments promotes MHC class II Ag 
presentation enhancing B and T cell interactions required for antibody (Ab) class 
switching and affinity maturation, critical aspects of humoral immunity (66, 67). 
 
Pathways of antigen delivery 
The exact mechanisms that lead to Ag presentation are not fully understood. 
While classically in this field, MHC class II molecules were thought to only 
present epitopes derived from membrane and exogenous sources that are 
internalized via endocytosis, our laboratory as well as others have shown MHC 
class II molecules present epitopes derived from cytoplasmic and nuclear 
sources that gain access to the endosomal/lysosomal network (4, 11, 51, 68-70). 
Peptide elution from mouse APCs have shown 20-30% of peptides bound to 
MHC class II molecules are derived from endogenous cytoplasmic sources such 
as actin, tubulin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (6). 
Peptide elution from MHC class II molecules from human B cells revealed 
greater than 85% of peptides were derived from endogenous sources the 
majority being from plasma and endosomal membrane proteins (7). These 
studies reveal that Ags utilize several pathways to encounter MHC class II 
molecules including endocytosis and autophagy pathways.    
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Endocytosis 
Ags can be internalized via several endocytic pathways including phagocytosis, 
receptor-mediated endocytosis and macropinocytosis, an actin dependent 
mechanism to engulf exogenous material. While phagocytosis and 
macropinocytosis drive the engulfment of large particulates and pathogens, 
receptor-mediated endocytosis facilitates the internalization of macromolecules 
(71, 72). Clathrin-mediated endocytosis is the process by which cell surface 
receptor-ligand complexes, such as Ag:BCR, are internalized (73). Clathrin-
mediated internalization of Ag via the BCR enhances Ag potency by as much as 
104 fold (74). During clathrin-mediated endocytosis, adaptor proteins, including 
AP2, associate with membrane signaling molecules at the plasma membrane. 
These adaptor proteins then associate with clathrin which forms the main coat 
directing membrane invagination to give rise to clathrin-coated vesicles 
containing receptors, MHC molecules and Ags. More than 60 proteins are 
involved in clathrin-mediated endocytosis, including HSC70 (75). HSC70 is 
involved in chaperoning clathrin, not only priming it for vesicle formation but also 
uncoating clathrin from vesicles as these mature into early endosomes (76).  
 
Autophagy pathways 
Autophagy is the process by which cells degrade unnecessary or dysfunctional 
cytoplasmic and nuclear components, essentially the process of “eating” oneself. 
Low levels of autophagy are detected in various cell types including B cells and 
dendritic cells (77, 78). When cells encounter different types of stress, they can 
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respond by altering the autophagy pathways to promote survival and alleviate the 
stress (79-89). These pathways help cells stabilize during times of stress by 
degrading modified proteins, eliminating pathogens, and removing toxic products. 
There are three types of known autophagy in mammalian cells: macroautophagy 
(MA), chaperone-mediated autophagy (CMA), and microautophagy. MA and 
CMA have been implicated in delivery of cytoplasmic Ags to the lysosomal 
network for processing and MHC class II presentation (77, 78, 90).  
 
During MA, a crescent shaped membrane is formed in the cytoplasm which can 
engulf some organelles, large portions of the cytoplasm, or intracellular 
pathogens during infection. The autophagosome then matures as it fuses with 
lysosomes and endosomes. Several protein complexes are required for MA, 
including Ulk1/2 complex, Beclin complex, ATG12/5 conjugation system, and the 
LC3 conjugation system (91). During MA, the LC3 conjugation system converts 
LC3I to LC3II by addition of the lipid phosphatidylethanolamine, leading to LC3II 
accumulation on the inside and outside of the autophagosome membranes (92). 
Acidification of autophagosomes by fusion to lysosomes leads to the degradation 
of internalized cargo protein as well as LC3II localized to the inside of the 
autophagosome membrane (92).  While MA is generally thought of as a bulk 
form of degradation, specific targeting of cytoplasmic proteins to autophagomes 
in a form of selective autophagy has been demonstrated. The MA receptor p62 
has been implicated in this process as it binds ubquitinated targets and links 
them to the LC3II protein on autophagosome membranes (93).  While 
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polyubiquitin chains branching from the ubiquitin lysine 48 are targeted for 
proteasomal degradation, chains branching from lysine 63 (K63) of ubiquitin are 
targeted for p62 recognition and degradation via MA (94). Interestingly, HSC70 is 
known to associate with protein aggregates, inducing ubiquitination of these 
substrates and targeting them for recognition by p62 (95).  
 
While MA can lead to bulk degradation of cytoplasmic proteins, CMA results in 
the degradation of specific target proteins. In CMA, the cytoplasmic chaperone, 
HSC70, binds to a pentapeptide (KFERQ-like) motif within proteins, guiding the 
protein to the lysosomal membrane (96). Given HSC70 functions in several 
different pathways for protein sorting, additional chaperones may be involved in 
CMA to promote client protein:HSC70 trafficking to lysosomes. Consistent with 
this, HSP90 has also been shown to be required for CMA (97, 98). On the 
lysosomal membrane a transmembrane protein, LAMP2A, associates with 
HSC70 and its client protein. By a process not well understood, the client protein 
is unfolded and translocated into the lysosome for degradation (98, 99).  
 
Heat shock chaperones 
The heat shock protein (HSP) family is a large group of proteins that function as 
chaperones to assist in protein folding and transport within cells. The HSPs were 
given their name based on the induction of many of these chaperones by heat or 
cell stress. While some of these chaperones can be induced, many are 
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expressed constitutively, indicating these proteins play important roles within the 
cell even under low or no stress conditions (100). 
 
The HSPs are divided into smaller families based on their molecular weight. Two 
such protein families are the HSP90 family with molecular weights of 90 kDa and 
the HSP70 family with molecular weights of 70 kDa (101). HSC70, sometimes 
referred to as HSC73, is a constitutively expressed cytosolic member of the 
HSP70 family which constitutes approximately 1% of the total protein within a cell 
(102). HSP90 is another cytosolic constitutively expressed HSP that belongs to 
the HSP90 family. Unlike HSC70 and many other HSP chaperones, HSP90 is 
not involved in protein folding, but rather appears to regulate signal transduction 
molecules and protein transport (103). Our laboratory has shown both HSC70 
and HSP90 are involved in MHC class II presentation of Ags. While experiments 
have shown addition of exogenous HSP90 binds proteins and assists in the 
presentation of extracellular Ags, intracellular HSP90 and HSC70 have been 
implemented in MHC class II presentation of endogenous cytoplasmic Ags (11, 
97).      
 
Chaperone HSC70 
HSC70 is an abundant intracellular chaperone that has numerous roles within 
cells (102).  HSC70 is constitutively expressed and is marginally induced by heat 
shock or other forms of cell stress (104). HSC70 functions as an ATPase, binding 
client proteins dependent on whether ADP or ATP is bound (102). As a 
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chaperone, HSC70 binds to hydrophobic and basic amino acids with a KFERQ-
like motif to prevent the unfolding and aggregation of proteins thereby facilitating 
numerous cellular processes (105-107). Unexpectedly, HSC70 is found both in 
the lumen of the lysosome as well as in the cytoplasm. Given the lack of a known 
signal sequence for membrane translocation, the mechanism by which HSC70 
crosses into the lysosome remains poorly defined. 
 
HSC70 plays an important role in several Ag trafficking pathways. A requirement 
for the ATPase activity of HSC70 was established for clathrin-mediated 
endocytosis (Figure 4) (108-110).  Furthermore, cytoplasmic HSC70 has been 
implicated in the targeting of proteins to the lysosome for CMA, while lumenal 
HSC70 may function in ratcheting or pulling proteins across the lysosomal 
membrane through a pore formed by LAMP2A (Figure 4) (106, 111, 112).  This 
multifaceted protein, HSC70, also guides specific proteins to the proteasome-
ubiquitin pathway (113, 114). Mirroring its association with lysosomal 
membranes, HSC70 associates with autophagosome membranes (Figure 4) 
(115-117). The purpose or cause of this association has not been well defined 
though it may be related to the role of HSC70 in selective autophagy.  
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The exact mechanisms which guide the specificity and the function of HSC70 in 
these cellular processes remain unknown. While a role for HSC70 association 
with client proteins with a KFERQ-like motif is important for CMA, whether this 
specificity is important in other functions of HSC70 is untested. Within cells, 
HSC70 associates with several cofactors capable of modulating its activity (118, 
119). Regulation of HSC70 by these cofactors is thought to occur by altering 
HSC70’s intrinsic ATPase activity (119, 120). Most of the cytoplasmic cofactors 
Figure 4. HSC70 plays a critical role in several pathways 
important for antigen trafficking and presentation. HSC70 is 
required for clathrin-mediated endocytosis, as the ATPase activity of 
HSC70 is required for coating and uncoating of vesicles. HSC70 is a 
key component of CMA, binding to client proteins and guiding them 
to the lysosomal membrane for interactions with LAMP2A. 
Furthermore, HSC70 in the lumen of the lysosome is required for 
translocation of these peptides. While association of HSC70 with 
autophagsome membranes has been detected, the function of this 
has not been established though it may be related to selective-
autophagy. During selective-autophagy, HSC70 and its co-
chaperone BAG3 guide client proteins to p62 and LC3, leading to 
their degradation via MA.   
Endosomes/Lysosomes+
MA+
Plasma+
+Membrane+
MHCII+
B+Cell+An7gen+Receptor+
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associate with the carboxy-terminus of HSC70 (119). Among the most well 
studied cofactors for HSC70 is BAG-1. BAG-1 binds the ATPase domain of 
HSC70 to influence ATPase activity (121, 122). With an ubiquitin-like domain, 
BAG-1 may help recruit HSC70 to the proteasome-ubiquitin pathway (118).  
Furthermore, another BAG family co-chaperone, BAG-3, has been implicated in 
the association of HSC70 with protein aggregates and the targeting of these 
aggregates to p62 and selective autophagy (95). Two other co-factors known to 
regulate HSC70, Hip and HSP40, also regulate ATPase activity (123, 124). HOP 
is another HSC70 cofactor. HOP is known to link HSC70 to the highly conserved 
heat shock protein HSP90, forming a multi-protein complex (125).  While 
individual co-chaperones have been implicated in specific functions, overlap 
occurs complicating assessment of HSC70 regulation. For example, studies have 
indicated BAG-1 guides client protein:HSC70 complexes to the proteasome, 
while other studies have revealed BAG-1 associates with LAMP2A, indicating a 
role for this co-factor in CMA (126, 127). 
 
As HSC70 is a critical component of several protein trafficking pathways, its role 
in MHC class II presentation may not be surprising (Figure 4)(128-130). Studies 
from our laboratory have revealed MHC class II presentation of cytoplasmic 
autoantigens via CMA is dependent on HSC70 (78). Furthermore, within the 
lumen of the lysosome HSC70 protects peptides from degradation by binding 
and delivering them to MHC class II molecules for presentation (131). 
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Autoimmunity 
In order to defend the body from foreign invaders, it is necessary for the immune 
system to distinguish self from non-self. The immune system has several 
mechanisms to facilitate this recognition, however sometimes these processes 
fail leading the immune system to attack the body in a process called 
autoimmunity. The exact pathways that lead to the loss of tolerance and the 
development of autoimmune disease remain elusive, though several factors 
including genetics and the environment likely contribute (132). 
 
Glutamic acid decarboxylase 65 (GAD) is a key autoantigen in type-1 diabetes, 
though its role in disease progression is not well understood (133). GAD is 
expressed in pancreatic beta cells and can associate with granules where insulin 
is stored, though the role of this enzyme within these cells has not been 
determined (133). Autoantibodies recognizing the self protein GAD are identified 
in 85% of newly diagnosed type-1 diabetes patients and studies have identified 
specific epitopes within the GAD protein can activate T lymphocytes (134, 135). It 
remains unclear how immune cells gain access to GAD as it is a cytoplasmic 
protein that associates with the luminal face of intracellular membranes, in part 
due to a pamitoylation of its amino-terminal domain (136). Studies within our 
laboratory have revealed B cells transduced to produce cytoplasmic GAD can 
display its epitopes on MHC class II molecules to activate T cells. Studies have 
further revealed that cytoplasmic GAD protein is processed by the chymotrypsin-
like activity of the proteasome and associates with HSP90 and HSC70 (78, 97, 
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137). HSC70 guides GAD through the CMA pathway, requiring LAMP2A for 
translocation through the lysosomal membrane. Furthermore, efficient 
presentation of GAD requires processing within the endosomal network by 
cathepsins (Figure 5) (11, 28).  
 
 
 
Protein malnutrition and immune response 
Globally, protein malnutrition remains problematic, affecting 1 in 8 individuals. 
Protein malnutrition adversely affects the neuroendocrine, cardiac and 
hematopoietic systems. Although poorly understood, protein restriction severely 
disrupts host immunity and responses to infection. Nutrition has a profound 
Figure 5. MHC class II presentation of the model autoantigen GAD. 
Our laboratory discovered that B cells expressing cytoplasmic GAD 
present epitopes derived from this Ag to activate T cells. Our laboratory 
has shown GAD is processed in the cytoplasm by the proteasome, 
associates with HSC70 and HSP90, and is translocated by CMA into 
lysosomes. Within lysosomes GAD is further processed by cathepsins 
before loading onto MHC class II molecules for presentation. 
MHC$Class$II:pep,de$
Plasma 
Membrane 
GAD 
Proteasome$
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LAMP2A 
HSP90 
Cathepsins 
CMA 
 21 
 
influence on host immunity as exemplified by hyper-inflammatory responses 
associated with high fat diets and connections between immune deficiency and 
malnutrition (138, 139). Furthermore, protein malnutrition has been linked to 
increased susceptibility to infection (140).  
 
Studies have shown protein malnourished children have reduced Ab responses 
as well as impaired T-cell mediated immunity (141). Reduced B cell expansion in 
response to bacterial infections was also observed in protein malnourished 
children (142). Studies using mice have shown a low protein/high fat diet results 
in a reduction in circulating Ab, increased instances of autoimmune disease and 
reduction in life span (143). Furthermore, mice receiving low protein/high fat diet 
have increased susceptibility to influenza infection (144). Studies in human B 
lymphoblasts have shown amino acid starvation reduces cathepsin activity 
influencing the epitopes presented by MHC class II molecules, raising questions 
about the ability of B lymphocytes to process Ag during severe stress (145). 
Induction of high affinity, long-lasting humoral immunity is dependent upon 
interactions between B and T lymphocytes. Taken together these studies indicate 
protein malnutrition may impair B and T cell mediated immunity, suggesting 
protein malnutrition may affect MHC class II Ag presentation. 
 
The effect of nutrient deprivation at the cellular level has been extensively 
studied. Cytoplasmic protein degradation is altered with increased degradation of 
nonessential proteins to provide nutrients for the cell through the induction of MA 
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(146). MA increases rapidly in cells deprived of amino acids, leading to ordered 
degradation of organelles, suggestive of a selectivity in degradation (146, 147). 
While MA is induced immediately upon nutrient stress, CMA has only been 
reported to be induced after 24 h of nutrient deprivation (106). Protein deprivation 
has also been shown to inhibit endocytosis of specific receptors, such as the 
transferrin receptor, on immune cells and impair the phagocytic capacity of 
macrophages (148, 149). While studies indicate proteasome activity is induced 
by serum deprivation, the effect of nutrient deprivation on lysosomal proteases is 
more controversial with some studies indicating increased activity and others 
suggesting inhibited activity (145, 150, 151). These data further suggest protein 
deprivation may alter the availability of Ags and capacity of MHC class II 
presentation by affecting Ag trafficking and degradation through these pathways. 
 
Research summary 
The adaptive immune response is severely disrupted in individuals who are 
malnourished. Furthermore, studies have suggested B and T cell interactions 
may be impaired in malnourished individuals. This led to the development of our 
hypothesis that protein deprivation alters MHC class II presentation in B cells, 
affecting B and T cell interactions. To assess this, media containing vitamins, 
amino acids and glucose but lacking serum, which contains numerous 
macronutrients, was used to culture cells. Studies assessed the ability of 
macronutrient deprived human B cell lines to present various model Ags 
including the BCR and GAD. The effect of macronutrient deprivation on key MHC 
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class II components was monitored. Studies were performed to identify the effect 
of macronutrient deprivation on Ag trafficking and degradation. Furthermore, 
alterations in Ag trafficking and proteolytic activity were assessed in 
macronutrient deprived primary peripheral blood human B cells. As serum is 
composed of numerous components, studies assessed the effect of various 
serum components on Ag trafficking. HSC70 plays an important role in several 
Ag trafficking pathways. Here, studies assessed the effect of macronutrient 
deprivation on the accessibility of this conserved chaperone. These studies 
reveal macronutrient sensing in B cells modulates Ag trafficking and presentation 
via accessibility of HSC70, offering a novel explanation for altered immune 
responses in protein malnourished individuals.  
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Materials and methods  
Cell culture 
The MHC class II DR4+ (homozygous for DRA1*0101,DRB1*0401) B-
lymphoblastoid cell line Priess was previously transduced using retroviral vectors 
to express wildtype human 65 kDa GAD, creating the PriessGAD (PG) cell line or 
with a vector coding the cDNA for a truncated form of GAD (CytoGAD) lacking 
the amino terminal domain provided by S. Baekkeskov UCSF (152). This N-
terminal deleted form of GAD while localized in the cytoplasm fails to associate 
with membranes in contrast to the full length GAD protein (136). PG cells were 
stably transfected to express influenza A matrix protein 1 (MP1)-LC3 fusion 
protein by lentiviral vector transduction provided by C. Münz, University of Zurich 
(77). PG were stably transfected to express HSC70 using the pcDNAZeo(-) 
plasmid containing cDNA encoding human HSC70 (D. Zhou) (78). All B-
lymphoblastoid cells were cultured in IMDM (Invitrogen) containing 50 U/ml 
penicillin and 50 µg/ml streptomycin (Gibco BRL Life Technologies) in the 
presence or absence of 10% heat inactivated fetal calf serum (FCS) (Hyclone). 
Cell lines transfected or transduced for ectopic gene expression were cultured for 
short periods with appropriate drugs to maintain gene expression. 
 
Several hybridoma T cell lines recognizing specific epitopes in the context of 
HLA-DR4 were used in this work: 2.18α is specific for an epitope encoded by the 
BCR (Ig κ 88-203), 33.1 is specific for the GAD273-285 epitope, 17.9 is specific for a 
peptide derived from human serum albumin (HSA64-76), 7A2-1736 is specific for a 
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peptide derived from the influenza MP1 (D. Cannaday, Case Western), and 33.4 
is specific for an epitope derived from MHC class I molecules; all were 
maintained in RPMI (Invitrogen) containing 10% fetal bovine serum (FBS) 
(Hyclone), 2 mM L-glutamine, 50 µM β-mercaptoethanol, 50 U/ml penicillin and 
50 µg/ml streptomycin. The IL-2 dependent HT-2 T cell line was maintained in 
RPMI 1640 (Invitrogen) containing 10% FBS, 50 µM β-mercaptoethanol, 50 U/ml 
penicillin, 50 µg/ml streptomycin and 20% T-STIMTM (BD Biosciences). 
 
Human whole blood was collected by venipuncture into a Sodium Heparin 
VacutainerTM (BD). Institutional approval for human blood collection was obtained 
for this study.  Blood was diluted 1:1 with Phosphate-Buffered Saline (PBS) prior 
to isolation of human peripheral blood mononuclear cells (PBMC) using a ficoll 
gradient. Primary B lymphocytes were isolated from fresh PBMC using CD19 Ab 
coated magnetic beads following manufacturer’s directions (Milltinyi Biotech). 
Isolated human CD19+ B cells were cultured in RPMI 1640, 50 U/ml penicillin and 
50 µg/ml streptomycin, in the presence or absence of 10% FBS.   
 
Antigen presentation assay 
To examine the effect of serum deprivation on MHC class II presentation, PG 
cells were used as APCs and co-cultured with T cells. Activation of T cells by 
APCs was monitored by IL-2 secretion. A bioassay using HT-2 cells was 
employed to detect IL-2. PG cells were cultured in media with or without serum, 
or with serum-free media supplemented with 0.01% bovine serum albumin (BSA, 
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Sigma) for up to 48 h. After incubation, PG cells were harvested and fixed in 
0.5% paraformaldehyde (PFA) for 8 min at room temperature and washed with 
media afterward. To detect exogenous HSA Ag presentation, PG cells were 
incubated with 20 µM HSA Ag for up to 12 h in media with or without serum prior 
to fixation. As a control to monitor surface MHC class II function without Ag 
processing, aldehyde-fixed cells were incubated with the appropriate synthetic 
peptide (10 µM) at 37oC for 6 h and then washed in media to remove excess 
peptide. The synthetic peptides GAD273-285 (IAFTSEHSHFSLK) or BCR (Igκ I 188-
203 KHKVYACEVTHQGLSS) were used for these latter studies. After treatment 
with peptide or Ag, fixed PG cells were washed, seeded at 4*104 cells per well in 
a 96 well plate and incubated with epitope-specific T cells at 2*104 cells in a total 
volume of 200 µl for 16 h at 37oC. T cell activation detected by IL-2 production 
was monitored using proliferation of the IL-2 dependent HT-2 cell line. HT-2 cells 
(5*103 cells per well) were incubated for 18 h at 37oC with the culture media from 
APC-T cell co-cultures.  [3H]-thymidine (2 µCi/well, PerkinElmer) was used to 
monitor HT-2 proliferation in response to IL-2 levels.  [3H]-thymidine was added 
to the HT-2 cells followed by an additional 8 h of culture at 37oC. After this 
incubation, HT-2 cells were harvested using a 96-well plate harvester (Scatron) 
and cellular incorporation of [3H] -thymidine into DNA was measured by liquid 
scintillation counting (Wallac Microbeta). The average counts per minute (cpm) of 
the isotype by HT-2 cells was recorded and used as a measure of Ag 
presentation. Results from three or more independent experiments were 
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determined and averaged. To compare differences in Ag presentation with B cell 
treatment, the relative fold change between averaged data was graphed.  
 
Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR)  
B cells were cultured with or without serum, or in media supplemented with 1% 
BSA for up to 48 h and harvested. RNeasy mini kit and QIAshredder (Qiagen) 
were used to isolate total cellular RNA following the manufacturer’s instructions.  
High-Capacity cDNA Reverse Transcription kit (Applied Bioscience) was used to 
generate cDNA. For analysis, TaqManTM Gene Expression Assays (Table 1) and 
TaqManTM Fast Universal PCR Master Mix (Applied Biosciences) were used. 
Here, we monitored mRNA expression of the DRα, DMβ and DOβ chains of 
these heterodimeric proteins because Ab regents exist to monitor the protein 
levels of these chains. The LAMP2 isoform primers were designed using the 
custom design Taqman interface (Lifescience Technologies). The following 
sequences were used for Forward (F), Reverse (R) and the Probe (P) to 
quantitate the mRNA of each isoform (Table 2). Samples were amplified by qRT-
PCR using the 7500 Real-Time PCR System (Applied Biosystems) for 40 cycles 
with the following parameters: 95˚C, 15 sec; and 60˚C, 1 m. GAPDH was used 
as the endogenous cellular mRNA reference and samples were normalized to 
the serum treated (Cont.) control sample.  
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Gene Assay product 
number 
GAD  Hs00609534_m1 
Ig κ Hs01692073_s1 
DRα Hs00219575_m1  
DMβ Hs00157943_m1 
DOβ Hs00157950_m1 
Ii Hs00269961_m1 
AEP (LGMN) Hs00271599_m1 
Cathepsin (CAT) A Hs00264902_m1  
CATB Hs00947433_m1 
CATS Hs00175407_m1 
TFEB Hs00292981_m1 
HSC70 (HSPA8) Hs00852842_m1 
HSP90α Hs00743767_sH  
HSP90β Hs01546478_g1 
GAPDH Hs02758991_m1 
 
 
 
 
 Gene  Primer Set Sequences 
LAMP2A F- AAC TTC CTT GTG CCC ATA GC  
R- AGC ATG ATG GTG CTT GAG AC 
P- CTC CTG CCA AGG CAG CTC CC 
LAMP2B F- AGA GTG TTC GCT GGA TGA TG 
R- TGC CAA TTA CGT AAG CAA TCA 
P- TCA AGC CTG AAA GAC CAG CAC CA 
LAMP2C F- AAG GGT TCA GCC TTT CAA TG 
R- ACA ATT ATA AGG AAG CCC AAG G 
P- CCA CAC CCA CTG CAA CAG GAA TAA GA 
 
 
 
 
Antibodies  
The following Abs were used for immunoblots, immunoprecipitations, ELISAs 
and flow cytometry assays to determine the effects of serum deprivation on MHC 
Table 1. Taqman gene expression assay 
product numbers and gene list. 
Table 2. Primer sequences for LAMP2 isoform Taqman assays. 
Listed here are the forward (F), reverse (R) and probe (P) 
sequences for each LAMP2 isoform Taqman probe designed by L. 
Perez.  
 29 
 
class II Ag presentation. To detect the MHC class II pathway components by 
immunoblot, the monoclonal mouse Ab Pin1.1 was used to monitor Ii chain and 
its fragments and DA6.147 (P. Cresswell, Yale) was used to monitor DRα. For 
flow cytometry, DR was monitored using a pre-conjugated DR-FITC Ab (BD 
Pharmingen), surface CLIP:MHC class II complexes were monitored using the 
pre-conjugated Cer-CLIP-FITC Ab (BD Pharmingen), DM was monitored using 
the pre-conjugated DM-PE Ab (BD Pharmingen), BCR was detected using the 
pre-conjugated Ig κ-PE Ab (Biosource), CD45R was detected using the pre-
conjugated CD45R-AF647 (eBioscience), TrF was detected using the mouse 
monoclonal B3/25 Ab with the anti mouse Ig-PE secondary (Dako) and DO was 
monitored using the mouse monoclonal DOβ clone DOB.L1 (Santa Cruz) with the 
anti mouse Ig-PE secondary. Other Ags detected on immunoblots include: LC3, 
monitored by the rabbit LC3b Ab (Cell Signaling); GAD, detected using the rabbit 
Ab to GAD65/67 (Sigma); HSC70, detected using a rat Ab to HSC70 
(Stressgen); BCR, detected using a mouse anti-IgG Ab (Jackson 
ImmunoResearch); MP1, detected using a mouse monoclonal Ab (AbD 
Serotech); and GAPDH, monitored using the mouse Ab to GAPDH (Millipore). 
HRP-conjugated secondary Abs recognizing mouse, rabbit or rat were used to 
detect the above primary Abs on immunoblots (Jackson ImmunoResearch). GAD 
Ag was immunoprecipitated using the GAD6 Ab (Sigma). For ELISAs, the BCR 
was detected using the mouse anti-IgG Ab (Jackson ImmunoResearch), MHC 
class II was detected using the mouse anti-MHC class II 37.1 Ab (L. Wicker), and 
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transferrin receptor (TrF) was detected using the mouse monoclonal B3/25 Ab 
(Ian Trowbridge). 
 
Flow cytometry 
Human B lymphoblasts or peripheral blood isolated B lymphocytes were cultured 
in vitro with or without serum or in media supplemented with BSA. These cells 
were then washed in FACS buffer and fixed with 0.5% PFA for 8 min at room 
temperature. Cells were further washed in FACS buffer and stained with primary 
Abs for surface markers for 60 min on ice. For intracellular staining, after fixation 
cells were permeabilized in 0.1% saponin in FACS buffer for 20 min at room 
temperature, washed, and blocked with normal rabbit serum (1:1000 dilution) for 
an additional 10 min at room temperature prior to Ab staining for intracellular 
proteins for 60 min on ice. Cells were washed in FACS buffer prior to analysis.  
 
Immunoblots 
PG cells were harvested and lysed in lysis buffer with 1% Triton-X pH 7.4 (10mM 
Tris Base, 150mM NaCl, 1% protease inhibitors cocktail (Sigma)) on ice for 10-
15 min. The resulting cell lysates were centrifuged at 14,000 rpm to pellet cell 
debri and nuclei. Protein concentration of cell lysates was determined using the 
BioRAD protein assay with BSA used as a protein standard. For gel 
electrophoresis, 50-100 µg of protein from cell lysates were mixed with reducing 
or non-reducing SDS sample buffer. The reducing SDS sample buffer containing 
β-mercaptoethanol was used in all cases other than for the detection of invariant 
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chain and MHC class II:GAD peptide complexes. SDS-PAGE was used to 
resolve the proteins in cell lysates, followed by the transfer of proteins to 
nitrocellulose membranes (GE Healthcare). These membranes were blocked 
using Blotto (5% powdered milk) overnight at 4oC prior to membrane incubation 
with primary Abs. Abs were typically diluted as recommended by the 
manufacturer. HRP-conjugated secondary Abs (Jackson ImmunoResearch) were 
used to detect primary Abs using enhanced chemiluminescence (Millipore) to 
visualize specific protein bands. Densitometry was carried out using ImageJ 
(NIH) to quantitate protein abundance. Protein levels (band density) were 
normalized relative to the band density of the same protein detected in serum 
treated control (Cont.). Results were graphed as the fold change of test samples 
relative to the serum treated control samples.  
 
Treatment of B cells with pharmaceuticals  
Protein turnover was monitored using cycloheximide (CHX) to inhibit protein 
synthesis. CHX was dissolved in sterile water. PG cells were grown in 10 µg/ml 
cycloheximide with or without serum for up to 12 h. Cells were harvested and 
lysed for immunoblot analysis. ImageJ was used to quantitate band density and 
sample band density was normalized to that of control samples cultured with 
serum. 
 
To track degradation of the MHC class II chaperone protein Ii chain, cells were 
cultured with the cysteine protease inhibitor leupeptin. Leupeptin (Sigma) was 
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solubilized in PBS and cells were treated with this agent at a concentration of 
500 µM for the times indicated at 37oC.  
 
Amiloride (Torcris), a sodium channel inhibitor which disrupts macropinocytosis 
as well as endocytosis, was dissolved in IMDM medium (153). Cells cultured in 
medium supplemented with BSA or as a control cultured with serum, were 
treated with 3 mM amiloride for 12 h at 37oC prior to flow analysis of surface 
levels of the BCR.  
 
While serum deprivation is known to induce MA, pharmaceuticals as well as 
infection by certain microbes can also induce MA. To examine the effect of the 
induction of MA on Ag presentation, PG cells were treated with the drug Torin1. 
Torin1, an inhibitor of mTOR leading to the activation of MA, was dissolved in 
DMSO (154). PG cells were cultured in media containing various concentrations 
of Torin1 for 16 h prior to fixation for Ag presentation assays and flow cytometry.  
 
Infection of B cells 
To examine the effect of microbe induction of MA on MHC class II Ag 
presentation, B cells were infected with Toxoplasma gondii. T. gondii is an 
obligate intracellular pathogen, known to induce MA (155). PG cells were 
infected with increasing multiplicities of infection (MOIs) at a density of 5*105 cells 
per mL and incubated overnight at 37oC prior to fixation for Ag presentation 
assays, immunofluorescence and flow cytometry. Infection was verified using 
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immunofluorescence. B cells were infected with a strain of T. gondii expressing a 
FITC tagged version of the parasite membrane protein TgSAG1 and the infection 
was halted by fixing cells with 4% PFA prior to DAPI staining. 
 
Macroautophagic flux 
Upon maturation and acidification of autophagosomes, the LC3II protein within 
these vesicles is degraded by acidic cathepsin proteases. To prevent this rapid 
proteolysis of LC3II, cells were treated with choloroquine (CQ), which neutralizes 
acidic organelles and slows proteolysis in these vesicles. PG cells were cultured 
with or without serum, and treated with and without 50 µg/ml CQ for up to 48 h, 
then harvested and lysed to detect LC3II levels via immunoblot analysis. The 
relative increase in cellular LC3II levels with addition of CQ is a measure of MA 
flux. Densitometry using ImageJ (NIH) was used to quantitate cellular protein 
levels. In these studies MA flux was defined as the basal cellular levels of 
LC3II/GAPDH subtracted from LC3II/GAPDH levels accumulating with CQ 
treatment (92). This number was normalized to serum treated cells and the 
relative fold change in MA flux was graphed. 
 
Protease assays 
The following assay to measure cathepsin activity in cell lysates was adapted 
from a protocol published by Kirshke and Wiedernanders (156). PG cells (2*107 
cells per sample) were cultured with or without serum for up to 12 h and 
resuspended in 0.5% Triton-X buffer pH 6.5 (20 mM Hepes, with HCL). Cells 
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were then lysed using the Dounce homogenizer for 15 strokes on ice. Cell 
homogenates were centrifuged at 1000 rpm for 5 minutes at 4°C to remove 
nuclei. To assess cathepsin (Cat) activity, the cleavage of specific substrates, 
including ZArgArgNMec for Cat B, ZPheArgNMec for Cat L, and ArgNMecHCl for 
Cat H (Sigma) was monitored using fluorometry. Cell homogenates were mixed 
with an activator buffer (specific for each cathepsin) along with the substrate (20 
µM) for either Cat L, Cat B, or Cat H. These reaction mixtures were incubated at 
37oC for 60 min. After the incubation, a buffer to stop the reaction (100 mM 
sodium monochloroacetate, 30 mM sodium acetate, 70 mM Acetic Acid, pH 4.3) 
was added to the mixture. Fluorometry with excitation at 360 nm and emission at 
460 nm was used to monitor the relative cathepsin activity in samples. Cathepsin 
activity of Cont. cells cultured with serum was normalized and set to 1. The fold 
change in the test samples cultured without serum was determined relative to the 
serum treated control samples and graphed.  
 
For real time analysis of cathepsin activity in live cells, Magic RedTM Cathepsin B 
and L Kits (Immunochemistry Technologies) were used according to a method 
previously published (157). B cells were treated with 6 µM protease substrates 
during the final hour of a 6 or 12 h incubation with or without serum, or in serum 
free media supplemented with BSA. Cells were harvested and washed in FACS 
buffer prior to fixation at room temperature in 0.5% PFA for 8 min. Flow 
cytometric analysis was used to detect the increased fluorescence with substrate 
cleavage. The average mean fluorescence of samples from three independent 
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experiments for control cells treated with serum was determined and the fold 
change relative to this average was graphed. 
 
The Proteasome-GloTM Chymotrypsin-like Cell-Based Assay (Promega) was 
used according to the manufacturer's instruction to assess proteasome activity in 
control cells cultured with serum and after 6 or 12 h of serum deprivation (158). 
The average proteasome activity from three independent experiments for control 
cells treated with serum was determined and the fold change for samples 
cultured without serum was determined relative to this average and graphed. 
 
Endocytosis assays and endosomal acidification 
Cellular uptake of 70 kDa dextran conjugated to tetramethylrhodamine 
(Invitrogen) was used to monitor fluid phase endocytosis (159). PG cells were 
incubated for 6 or 12 h with or without serum in the presence of 100 µg/mL 
dextran. Cells were harvested and fixed using 0.5% PFA prior to analysis by flow 
cytometry. The mean fluorescence intensity (MFI) for each sample was 
normalized to the serum feed control sample for each time point, allowing 
calculation of the fold change relative to the serum control which was graphed in 
this analysis. 
 
To assess endosomal acidification, cellular uptake of FITC-rhodamine-dual 
conjugated dextrans (Invitrogen) was assessed. Cells were treated with the dual 
labeled dextran under conditions similar to the endocytosis assay. While the 
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rhodamine fluorophore is resistant to pH, the fluorescence of the FITC 
fluorophore is diminished upon reaching acidic endosomal compartments (160). 
The average ratio of the FITC:rhodamine MFI was determined by flow cytometry 
in three independent studies. In each analysis the fold change in the 
FITC:rhodamine ratio was determined for treated cells relative to that of the Cont. 
cells cultured with serum.  
  
Endocytosis of cell surface proteins and receptors such as BCR, MHC class II, 
and TrF was monitored using a method previously published by our laboratory 
(161). Cell surface proteins were biotinylated using the reagent EZ-link Sulfo-
NHS-SS-Biotin (Thermo, 21328), which modifies the lysines in proteins and can 
be released by disulfide reduction. Biotinylated cells were incubated for 30 min at 
37°C in IMDM containing 10% FBS, in serum free media or media supplemented 
with 1% BSA. As a control, some biotinylated cells were incubated at 4°C during 
this 30 min incubation to block endocytosis. After this incubation, some cells 
washed in a glutathione solution (0.05 mM glutathione, .075 mM NaCl, 0.001 mM 
EDTA, 10% FBS and .075 NaCl) to strip any remaining surface biotinylation. 
Cells were washed in Hanks balanced salt solution (HBSS) to remove reductants 
and any unconjugated biotin. Then cells were lysed for determination of protein 
concentrations. To quantitate the biotin levels on specific proteins, cellular 
proteins were captured using a sandwich ELISA. ELISA plates were coated with 
anti-IgG Ab (Jackson ImmunoResearch, used at 2 µg/mL), anti-TrF B3/25 Ab or 
anti-MHC class II 37.1 Ab (L. Wicker, used at 1 µg/mL). Cell lysates were 
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incubated on these plates for Ab capture. After extensive washing and blocking, 
biotin-labeled proteins were detected using streptavidin-HRP and the colorimetric 
dye 2,2'-azino-bis (ABTS). Absorbance was normalized to protein concentrations. 
BCR endocytosis was graphed as a percent of the total surface BCR (a control 
that was not stripped). 
 
Subcellular fractionation 
To determine if serum starvation altered GAD intracellular localization, 
membrane and cytoplasmic fractions of cells were isolated using a method 
previously published (162). PG cells (1*107 per condition) were cultured with or 
without serum or in medium supplemented with 1% BSA for 12 h. These cells 
were washed in HBSS (Gibco BRL), and resuspended in ice cold 
homogenization buffer (10 mM Hepes, 250 mM sucrose with a protease inhibitor 
cocktail from Sigma). To disrupt the cell plasma membrane and release 
cytoplasm and membranes including organelles, cells were passed 15 times 
through the Balch homogenizer on ice. Nuclei were removed by centrifugation at 
1600 rpm at 4°C for 10 min. These homogenates were further centrifuged at 
100,000 rpm at 4°C for 1 h to pellet cell membranes. The supernatant from this 
step was collected as the cytoplasmic fraction. The membranes were solubilized 
in an extraction buffer (0.01 mM Hepes, 150 mM NaCl, 2% Triton X-100 with the 
protease inhibitor cocktail from Sigma). Samples of cell membranes and 
cytoplasmic proteins were then separated on SDS-PAGE gels using the western 
blot protocol. 
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Serum fractionation and macronutrient supplementation of media 
Heat inactivated FCS was fractionated using Centricon concentrators with 
molecular mass cut-offs of 30 kDa and 10 kDa according to manufacturer’s 
instructions (Amicon). Macromolecules retained by the 30 kDa filter (termed the 
>30 kDa fraction), and molecules flowing through the filters were used as the <30 
kDa and <10 kDa fractions, respectively. PG cells were cultured in IMDM media 
supplemented at 10% with these various serum fractions for 12 h before cell 
harvest. 
 
Alternatively, cells were cultured in serum-free media supplemented with defined 
macromolecules, including 1% (wt/vol) BSA (Sigma), ovalbumin (OVA) (Sigma), 
hen egg lysozyme (HEL) (Sigma), or dextrans (70 kDa, 40 kDa, or 10 kDa) 
(Invitrogen).  
 
Osmolarity and viscosity 
To determine whether addition of serum or macronutrients significantly affected 
osmolarity or viscosity of the solution, IMDM media containing 50 U/ml penicillin 
and 50 µg/ml streptomycin alone or supplemented with 10% FCS or 1% BSA or 
dextran was filtered and shipped to ACTA laboratories for analysis. 
 
Electron microscopy 
PG cells were cultured with or without serum or in media supplemented with BSA 
for 12 h. Cells were harvested, washed and fixed for 1 h in 2% glutaraldhyde. 
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Cells were washed in PBS and lightly spun to pellet at 900 rpm for 5 min. Cells 
were then sectioned and prepared for imaging by the Indiana University School 
of Medicine Microscopy core.  
   
Co-immunoprecipitation of proteins 
B cells were cultured in media with or without serum or in serum-free media 
supplemented with 1% BSA for 12 h. Cells were lysed in 10 mM Tris buffer pH 
7.4 (150 mM NaCl, 1% N-octyl-β-glucopyranoside with a protease inhibitor 
cocktail from Sigma) for 20 min on ice. Lysates were centrifuged at 14,000 rpm 
for 10 min. Normal rabbit serum (1:1000) and Protein G-Sepharose (Sigma) were 
added to lysate at 4°C for 30 min as a preclear step followed by removal of the 
Sepharose by centrifugation. GAD Ab (2.5 µg/tube of GAD6, Sigma) or an 
isotype-matched control Ab were added and incubated overnight at 4°C to co-
precipitate associated proteins. Protein G-Sepharose were added to each cell 
lysate at 4°C for 2 h. Centrifugation at 2000 rpm for 2 min was used to pull down 
Sepharose-Ab-Ag complexes. These complexes were washed five times in cold 
PBS (Gibco). Reducing sample buffer (40 µl) containing β-mercaptoethanol was 
added to each sample prior to boiling samples in water for 10 min to release 
proteins from the Ab and beads. Samples were then resolved on 10% SDS-
PAGE and analyzed by immunoblotting for molecules such as HSC70. The ratio 
of HSC70/GAD  co-immunoprecipitating in cells was set to 1 for control serum 
treated cells and the fold change relative to this ratio was graphed for each 
experimental condition.  
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CMA peptide translocation assay 
To assess the relative rate of CMA in treated cells, a biotin-labeled peptide is 
electroporated into the cytoplasm of cells. Incubation of these cells at 37oC 
allows transport of this peptide from the cytoplasm into the lysosomal network by 
CMA. In the lysosomal network this peptide can associate with MHC class II 
molecules. Detection of biotin-peptide:MHC class II complexes allows a relative 
assessment of the rate of CMA. To assess the affect of serum deprivation on 
CMA, PG cells (1*107 per condition) were washed three times in ice cold PBS 
(Gibco) prior to addition of a C-terminal biotin-labeled GAD273-285 peptide (20 
mM). The peptide was delivered into the cytoplasm of the cell using 
electroporation (270V, 125mF, pulse twice) using the BIO-RAD gene pulser II. To 
determine the non-specific association of the peptide with the surface of cells, 
control cells were incubated with peptides but not subjected to electroporation. 
During the assay, low levels of peptide can bind surface MHC class II molecules. 
Given our goal to detect only intracellular MHC class II peptide complexes 
formed as a result of CMA, cells were treated to remove surface MHC class II 
peptides. To remove any peptide bound to cell surface MHC class II complexes, 
cells treated with or without electroporation were washed twice in ice cold 160 
mM NaCl then resuspended in 160 mM NaCl/Citric acid, pH 4.0 and incubated 
30 min on ice. This low pH removed only peptides from exposed cell surface 
MHC class II complexes (11). Cells were then neutralized in ice cold serum-free 
media and washed another two times in ice cold media containing serum. Cells 
were subsequently cultured in media with or without serum at 37oC for 16h. Cells 
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were then harvested for immunoblot analysis to detect biotin-GAD273-285/MHC 
class II complexes. 
 
Statistics 
Statistics were determined using GraphPad Prism 6.0 (GraphPad Software, Inc.). 
Data depict mean from 3 or more independent experiments, +/- SEM unless 
otherwise noted. P values less than 0.05 were considered statistically significant 
with * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. The statistical 
method is listed in each figure. When multiple test were used to assess a figure, 
the ANOVA was depicted by * and the Student’s t test was depicted by #, with    
# p < 0.05 and ## p < 0.01. 
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Results 
 
Chapter 1. 
Serum deprivation altered MHC class II presentation of endogenous 
antigens 
 
Induction of high-affinity, long-lasting humoral immunity depends on B and T cell 
interactions.  Intracellular trafficking pathways play a key role in promoting B and 
T cell contact necessary for adaptive immune responses. Ags are delivered into 
the endosomal network by various transport routes including receptor-mediated 
uptake, macroautophagy (MA), and chaperone-mediated autophagy (CMA) (9, 
145). In response to stress, cells can upregulate or downregulate these transport 
pathways to maintain homeostasis. During nutrient stress, cells frequently 
upregulate MA or CMA to promote cell survival (106, 163). Whether fluctuations 
in the activity of these pathways during nutritional stress influence immune 
recognition had not been previously explored. 
 
To elucidate the effect of nutrient stress or deprivation on MHC class II Ag 
presentation, studies were carried out using an EBV transformed human B 
lymphoblast PriessGAD (PG) cell line as an APC. Use of this cell line and model 
Ags offered the opportunity to examine how nutrient deprivation alters MHC class 
II Ag presentation. To monitor MHC class II presentation through the classical 
endocytic network, presentation of the endogenously expressed membrane BCR 
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Ag and the exogenous Ag human serum albumin (HSA) were monitored in PG 
cells. The BCR alone or complexed with Ag is constitutively internalized into 
endosomes by receptor-mediated endocytosis. Here, cathepsins digest the BCR 
and Ags yielding peptides for presentation by MHC class II molecules (62, 63). 
To examine CMA-dependent Ag presentation, PG cells were retrovirally 
transduced to express the cytosolic Ag glutamic-acid decarboxylase (GAD) (11). 
Our laboratory has shown GAD accesses the CMA pathway, requiring HSC70 as 
well as LAMP2A to translocate into lysosomes where cathepsins further process 
this Ag. The resulting GAD epitopes can then associate with MHC class II 
molecules within the endosomal network (78). To monitor MHC class II 
presentation through the MA pathway, PG cells were transduced to express the 
influenza A matrix protein 1 (MP1) that is targeted to autophagosomes by linkage 
to LC3. This MP1-LC3 undergoes lipid conjugation promoting its association with 
autophagosome membranes leading to MP1-LC3 uptake and degradation within 
these vesicles (164). Using these different model Ags, the effects of nutrient 
deprivation on MHC class II Ag presentation was investigated in B cells cultured 
in the absence of serum to mimic nutrient deprivation.  
 
Serum deprivation altered MHC class II presentation of the cytoplasmic 
GAD antigen 
The effect of nutrient deprivation on MHC class II Ag presentation was assessed 
by culturing PG cells in serum-free media rich in amino acids, simple carbon 
sources and vitamins but lacking the complex macromolecules found in serum. 
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PG cells were cultured in the presence or absence of serum for 6, 12, 24 or 48 h 
prior to fixation, which halts Ag processing and subsequent incubation with T 
cells that recognize the specific GAD 273-285 epitope displayed in the context of 
HLA-DR4 on PG cells. Compared to cells cultured with serum, serum deprivation 
reduced MHC class II presentation of GAD epitopes by approximately 50% 
(Figure 6 A). Serum deprivation did not alter cell viability as determined by 
trypan blue staining (data not shown).  
 
 
 
To determine if impaired GAD presentation during serum deprivation was due to 
altered co-stimulatory molecule activity or MHC class II surface levels, MHC 
class II presentation of a pre-processed synthetic GAD peptide was assessed. 
After serum starvation and fixation, PG cells were pulsed with the synthetic 
GAD273-285 peptide prior to incubation with T cells for analysis of MHC class II 
Figure 6. Serum deprivation impaired MHC class II presentation of the 
endogenous GAD antigen. (A) MHC class II presentation of endogenous GAD in 
PG cells cultured with (Cont.) or without serum for up to 48 h prior to fixation and 
incubation with T cells. One-way ANOVA, followed by Dunnett’s multiple 
comparisons correction. (B) MHC class II presentation of the synthetic GAD 
peptide in PG cells cultured with or without serum for up to 48 h, fixed and pulsed 
with the synthetic peptide for 6 h prior to washing and incubation with T cells. Data 
depict mean from 3 or more independent experiments, ±SEM. *p<0.05 
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presentation. This synthetic GAD peptide will directly load surface MHC class II 
molecules bypassing any processing steps. While MHC class II presentation of 
the endogenous Ag was significantly impaired during serum deprivation, MHC 
class II presentation of the synthetic GAD peptide was unaltered (Figure 6 B).  
  
Long periods, but not short, of serum deprivation altered expression of 
MHC class II pathway components  
Several molecules play critical roles in the MHC class II Ag presentation pathway 
as demonstrated in Figure 1. MHC class II molecules are guided to endosomes 
by Ii chain, which is proteolytically cleaved by cathepsins (12). The molecular 
editor, DM, then removes the Ii chain fragment CLIP from the MHC class II 
binding groove, facilitating antigenic peptide binding (19). DM activity is regulated 
by DO association (35). The resulting MHC class II:peptide complexes and some 
co-stimulatory molecules recycle from endosomes to the cell surface to engage T 
cells.  
 
To further elucidate the effect of serum deprivation on the MHC class II Ag 
presentation pathway, mRNA and protein levels of MHC class II components 
were assessed. PG cells cultured with (Cont.) or without serum for 6, 12, 24 or 
48 h were harvested and the relative expression of DRα (MHC class II 
molecules, DR), CD74 (Ii chain), DMβ (DM), and DOβ (DO) mRNA were 
assessed. While prolonged serum deprivation significantly reduced DMβ mRNA, 
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serum starvation for up to 12 h did not significantly alter mRNA expression of the 
MHC class II components (Figure 7 A-D).  
 
 
 
As GAD utilizes the CMA pathway to translocate into lysosomes, mRNA 
expression of the membrane channel protein LAMP2 was assessed. There are 
three isoforms of LAMP2: LAMP2A which functions in CMA, LAMP2B which may 
play a role in MA, and LAMP2C which has recently been shown to play a role in 
Figure 7. Prolonged, but not short, periods of serum deprivation altered 
mRNA expression of MHC class II pathway components. PG cells were 
cultured with (Cont.) or without serum for up to 48 h and mRNA expression of 
MHC class II components, (A) DRα, (B) CD74 (Ii chain), (C) DMβ and (D) 
DOβ  was monitored relative to GAPDH. One-way ANOVA followed by 
Dunnett’s multiple comparisons correction. Data depict mean from 3 
independent experiments, ±SEM. *p<0.05 
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RNA translocation from the cytosol to the lysosome (78, 165, 166). Serum 
deprivation did not alter expression of LAMP2A or LAMP2B mRNA, however 
prolonged serum deprivation decreased LAMP2C expression, though not 
significantly (Figure 8). 
 
 
 
While the mRNA levels of the key co-factors for MHC class II molecules such as 
Ii chain, DM and DO remained largely unchanged, protein expression and 
function may be altered by serum deprivation. To assess the expression of these 
proteins, PG cells were cultured with or without serum for 12 h, fixed and stained 
for surface MHC class II molecules (DR) or intracellular DM and DO (Figure 9 A, 
C-E).  While MHC class II molecules and DM remained unaltered during 12 h 
Figure 8. Effects of serum deprivation on LAMP2 mRNA 
expression. PG cells were cultured with (Cont.) or without 
serum for up to 48 h and mRNA expression of the LAMP2 
isoforms was monitored relative to GAPDH. Two-way 
ANOVA, followed by Dunnett’s multiple comparisons 
correction. Data depict mean from 3 independent 
experiments, ±SEM.  
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serum deprivation. DO expression was reduced by approximately 25%. DO binds 
to DM preventing its removal of CLIP from MHC class II molecules (37). As DM 
helps remove CLIP from the MHC class II binding groove, monitoring surface 
levels of CLIP:MHC class II complexes gives a relative readout of DM function 
(19). To assess DM function, PG cells were cultured with or without serum for 12 
h and stained for surface CLIP:MHC class II complexes.  Serum deprivation did 
not alter surface levels of CLIP:MHC class II complexes, indicating the reduction 
in DO protein levels during serum deprivation did not alter DM function (Figure 9 
B and E).  
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To further assess the expression of MHC class II components, cellular levels of 
MHC class II molecules and Ii chain were assessed by immunoblot. MHC class II 
and Ii chain protein levels were overall unchanged by serum deprivation after 12 
h (Figure 9 F). These data reveal, while serum deprivation for 6 or 12 h impaired 
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Figure 9. Serum deprivation for up to 12 h did not alter MHC class II 
protein levels. PG cells were cultured for 12 h with (Cont.) or without 
serum, fixed, and stained for flow cytometry analysis of surface expression 
of (A) MHC class II (DR) and  (B) CLIP bound to MHC class II (CLIP) as a 
read out of DM activity. For intracellular detection of proteins, fixed cells 
were permeabilized prior to staining for (C) total DM expression and (D) 
total DO expression. Isotype matched control Ab staining is shown as grey 
shaded region. (E) Quantitation of relative protein in PG cells cultured in 
serum free-media for 12 h as compared to Cont. cell MFI (normalized to 1 
and depicted as dotted line). Multiple T-Test to Cont. (normalized to 1), 
Holm-Sidak multiple comparisons correction. Data depict mean from 3 
independent experiments, ±SEM. *p<0.05. (F) PG cells were cultured for 6 
or 12 h with or without serum and lysed for immunoblot analysis of Ii chain 
and MHC class II (DRα). GAPDH was used as a loading control. Data 
representative of 3 or more experiments.  
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MHC class II presentation of GAD, the protein levels of MHC class II components 
appear unaltered during this time frame. 
 
While short periods (up to 12 h) of serum deprivation did not alter MHC class II 
components, extending serum deprivation for 48 h significantly altered 
expression of MHC class II components (Figure 10). Significant reductions were 
observed in DM protein levels as well as CLIP:MHC class II complexes on the 
cell surface (Figure 10 B, C, and E). While not statistically significant, DR protein 
levels were reduced at 48 h in all three independent trials (Figure 10 A and E). 
Altered DM activity as well as reduced surface expression of DR, would 
contribute to impaired GAD presentation at these prolonged periods of nutrient 
stress (>24 h). Thus, the reduction in expression and function of MHC class II 
components likely contributes to impaired MHC class II presentation of GAD 
during prolonged serum deprivation. 
 
 51 
 
 
 
Mechanisms used to induce macroautophagy, distinct from serum 
deprivation, altered MHC class II components 
In vivo and in vitro, cellular deprivation of serum proteins is known to induce MA, 
a process by which LC3II decorated autophagosomes engulf cytoplasmic 
molecules for degradation to favor, in some cases, immune recognition (146). 
Figure 10. Prolonged serum starvation reduced protein levels and 
function of MHC class II pathway components. PG cells were 
cultured for 48 h with (Cont.) or without serum, fixed, and stained for 
flow cytometry analysis of surface expression of (A) MHC class II (DR) 
and (B) CLIP bound to MHC class II (CLIP). For intracellular protein 
detection, fixed cells were permeabilized prior to staining for (C) total 
DM expression and (D) total DO expression. Isotype matched control Ab 
staining is shown as grey shaded region. Data are representative of 
three or more independent experiments. (E) Quantitation of relative 
protein in PG cells cultured in serum free-media for 12 h as compared to 
Cont. cell MFI (normalized to 1 and depicted as dotted line). Multiple T-
Test, Holm-Sidak multiple comparisons correction. Data depict mean 
from 3 independent experiments, ±SEM. *p<0.05 
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Upon maturation and acidification of autophagosomes, LC3II protein within these 
vesicles is degraded. Addition of chloroquine (CQ) impairs acidification of 
autophagosomes, blocking autophagosomal degradation of LC3II. Cellular levels 
of MA or the MA flux can be monitored by tracking LC3II protein expression in 
response to nutrient stress (92). As expected, MA flux was amplified in cells 
cultured without serum as compared to control serum treated cells between 6-24 
h. By 48 h cultivation in the absence of serum, the induction of MA had subsided 
(Figure 11).  
 
 
 
To examine whether the induction of MA was responsible for the observed 
alterations in GAD presentation during serum deprivation, PG cells were treated 
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Figure 11. Serum deprivation induced macroautophagy. (A) PG cells were 
cultured with (Cont.) or without serum for 6 or 12 h in the presence or absence 
of CQ to block lysosomal acidification and LC3II degradation. Cells were 
harvested, and lysed for immunoblot analysis of LC3II expression. LC3II 
expression was compared to Cont. cells and GAPDH was used as a loading 
control. (B) To quantitate MA flux, LC3II levels were normalized to the loading 
control GAPDH and LC3II:GAPDH basal levels were subtracted from the 
induced CQ treated levels. MA flux in Cont. cells was normalized to 1 and fold 
change relative to this control graphed. One-way ANOVA, followed by Dunnett’s 
multiple comparisons correction. Data depict MA flux from 3 independent 
experiments, ±SEM. *p<0.05 
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with Torin1. Torin1 is an inhibitor of mTOR, a key inhibitor of MA (167). PG cells 
treated with up to 600 nM Torin1 for 16 h demonstrated reduced levels of 
endogenous GAD presentation similar to those observed with serum deprivation 
(Figure 12 A). Treatment at these concentrations of Torin1 did not affect cell 
viability as assessed by trypan blue staining (data not shown). This initial result 
suggested the induction of MA may be responsible for altered GAD presentation. 
However, analysis of the MHC class II pathway components revealed that while 
MHC class II surface expression was unaltered by Torin1 treatment, DM function 
was significantly enhanced, as assessed by surface levels of the CLIP:MHC 
class II complexes (Figure 12 B, C). Studies from our lab have shown GAD 
epitope presentation is sensitive to DM function, potentially explaining the 
reduced levels of GAD presentation in cells treated with Torin1 (28). Though 
treatment with the MA inducer Torin1 resulted in reduced MHC class II 
presentation of GAD, the mechanism here appears different than that of serum 
deprivation, as serum deprived cells did not experience altered DM activity. 
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Intracellular pathogens have adapted multiple mechanisms to escape host cell 
detection. Several pathogens have developed the means to alter the 
endocytic/lysosomal pathway, altering autophagy and endocytic trafficking. 
These mechanisms not only protect the pathogen from cell autonomous 
elimination, but also may prevent the activation of the immune system by altering 
MHC class II presentation (168, 169). Several pathogens including herpesvirus, 
influenza, Listeria and Toxoplasma have been shown to manipulate MA (155, 
170-172). Toxoplasma gondii induces host cell autophagy by secretion of the 
hormone abscisic acid (ABA) and manipulates vacuolar trafficking to acquire 
nutrients (155, 173). To assess whether alterations in MA during T. gondii 
infection affect MHC class II Ag presentation, PG cells were infected with T. 
gondii for 16 h. As these were the first studies to assess T. gondii infectivity of B 
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Figure 12. Torin1 treatment altered DM function. (A) PG cells cultured 
in the presence of the vehicle (Control) DMSO or various concentrations 
of Torin1 for 16 h were fixed and incubated with T cells to monitor MHC 
class II presentation of GAD or fixed and stained with Abs to assess 
surface (B) MHC class II and (C) CLIP:MHC class II complexes as an 
indicator of DM function. *p<0.05, **p<0.01, One-way ANOVA, Dunnett’s 
multiple comparisons correction. Data representative of two or more 
independent experiments, ±SEM. 
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cells, PG cells were harvested and immunofluorescence was used to assess 
intracellular localization of T. gondii (Figure 13 A). Infection of B cells with T. 
gondii at these MOIs and time points did not significantly affect cell viability as 
assessed by trypan blue staining (data not shown). Infection with T. gondii 
significantly reduced MHC class II presentation of GAD epitopes, though this is 
likely due to significant reductions in MHC class II surface levels (Figure 13 B 
and C). These studies indicate T. gondii infection may globally alter MHC class II 
Ag presentation, as infection reduced surface expression of MHC class II in B 
cells. While infection with T. gondii impaired GAD presentation by MHC class II 
molecules, the reduction in MHC class II observed during infection differs from 
the serum starvation and Torin1 experiments. The results suggest this model 
using T. gondii may disrupt Ag presentation by a different mechanism, perturbing 
MHC class II gene expression. 
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Serum deprivation enhanced MHC class II presentation of antigens through 
the macroautophagy pathway but impaired presentation of antigens 
through other pathways 
To further elucidate the mechanisms by which short periods (up to 12 h) of serum 
deprivation altered MHC class II presentation, the presentation of epitopes 
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Figure 13. Toxoplasma gondii infection of B cells reduced 
MHC class II surface expression. (A) PG cells were  infected 
with T. gondii (MOI 5) for 16 h, fixed and immunofluorescence was 
used to detect nuclei (DAPI, blue) and  a T. gondii surface protein 
(TgSAG1, green). (B) PG cells were  infected with T. gondii (MOI 1, 
5 and 10) for 16 h, fixed and MHC class II presentation of GAD 
was monitored. As a control, supernatant from T. gondii growth 
culture was collected, filtered (0.2 µm) and added to PG for 16 h 
prior to fixation of these cells and T cell co-culture to monitor MHC 
class II presentation. (C) PG cells were infected with T. gondii for 
16 h, fixed and MHC class II (DR) surface expression assessed by 
flow cytometry. Data representative of 2 or more independent 
experiments, ±SD. 
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derived from several model Ags delivered into the endosomal network via distinct 
routes was monitored. To monitor presentation of an Ag which requires the MA 
pathway, studies were carried out in PG transduced with the MP1-LC3 fusion 
protein (77). MHC class II presentation of epitopes derived from this cytoplasmic 
Ag, MP1-LC3, was increased in cells grown in serum-free media compared to 
serum treated cells (Figure 14 A). As MA was increased in these B cells, 
upregulation of MHC class II presentation of epitopes derived from MP1 was not 
unexpected (Figure 11). Interestingly, MHC class II presentation of epitopes 
derived from the exogenous HSA Ag and epitopes derived from the membrane B 
cell receptor (BCR) Ag was impaired, both of these Ags traffic by endocytosis for 
processing and to gain access to MHC class II molecules (Figure 14 B, C). MHC 
class II presentation of the synthetic BCR peptide (Igκ I 188-203) was not altered by 
serum deprivation, further suggesting alteration in MHC class II presentation 
were not caused by altered co-stimulatory signaling or MHC class II surface 
expression (Figure 14 D). 
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Together the data presented in this chapter indicate that serum deprivation alters 
MHC class II presentation of specific Ags and that these disruptions are 
dependent on the processing route. MHC class II presentation of the MA-
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Figure 14.  Serum deprivation altered MHC class II presentation of 
select antigens in PG cells. (A) MHC class II presentation of an epitope 
derived from the MA targeted MP1 Ag in PG cells cultured with (Cont.) or 
without serum for 6 or 12 h. One-way ANOVA followed by Dunnett’s 
multiple comparison. (B) PG cells were cultured with or without serum in 
the presence of 20 uM exogenous HSA Ag for 12 h prior to fixation and 
detection of MHC class II presentation of an epitope derived from HSA. 
Student’s T-Test. (C) MHC class II presentation of an epitope derived from 
the membrane Ag BCR in PG cells cultured with or without serum for 6 or 
12 h. One-way ANOVA followed by Dunnett’s multiple comparisons 
correction. (D) After culture of PG cells with or without serum for 12 h, 
cells were fixed and incubated with the synthetic BCR peptide for 6 h prior 
to incubation with T cells to monitor MHC class II presentation of the BCR 
peptide. *p<0.05, **p<0.01.Data depict means from three or more 
independent experiments, ±SEM.  
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targeted Ag MP1 was significantly enhanced by serum deprivation, while 
presentation of GAD, a CMA-targeted Ag, and the BCR as well as HSA, 
endocytic Ags, was impaired. While MHC class II presentation of several Ags 
was altered, the classical MHC class II components including MHC class II 
molecules, DM, DO and Ii chain remained largely unchanged during short (up to 
12 h) periods of serum starvation. However, during extended periods of serum 
deprivation, expression of several MHC class II components was significantly 
impaired, likely contributing to altered Ag presentation. Furthermore, serum 
deprivation significantly induced MA flux. While the use of chemical regulators or 
infection to mimic MA induction disrupted GAD Ag presentation, these treatments 
also altered the expression of key components of the MHC class II Ag 
presentation pathways, potentially contributing to altered Ag presentation.  
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Chapter 2. 
Serum deprivation altered trafficking of endogenous antigens 
 
Whereas endocytosis of exogenous Ags promotes the classical MHCII Ag 
presentation pathway, MA, bulk autophagy, and CMA, a selective form of 
autophagy dependent on HSC70, play critical roles in MHC class II presentation 
of intracellular Ags (9). While MHC class II components were unaltered by serum 
deprivation, MHC class II presentation of Ags that utilize both the endocytic and 
CMA routes of Ag delivery was impaired, though presentation of Ags through MA 
was enhanced. During nutrient stress, cells upregulate MA to promote survival 
and to salvage critical building blocks (106, 163). To further elucidate the effect of 
serum deprivation on MHC class II Ag presentation, Ag degradation and 
trafficking were assessed. The BCR, alone or complexed with Ag, accesses the 
classical endocytic pathway to transit from the cell surface into the endosomal 
network. The cytoplasmic Ag GAD utilizes CMA to reach the endo/lysosomal 
network. Within endosomes and lysosomes, cathepsins digest the BCR and GAD 
yielding peptides for presentation by MHC class II molecules (62, 63). Alterations 
in the expression, degradation or trafficking of these Ags may alter the availability 
of epitopes for MHC class II presentation.  
 
Serum deprivation altered antigen degradation 
To elucidate the mechanism by which serum deprivation altered epitope 
selection for MHC class II presentation, MP1, GAD and BCR protein expression 
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was assessed in B cells. While cellular MP1 protein levels dropped with serum 
deprivation (Figure 15 A), BCR and GAD protein levels increased (Figure 15 B 
and C). To determine whether these alterations were due to changes in Ag 
synthesis or degradation, PG cells were treated with a protein synthesis inhibitor, 
cycloheximide. MP1 protein levels decreased quickly with serum deprivation 
regardless of cycloheximide treatment, consistent with MA-induced degradation 
of this Ag (Figure 15 A). Conversely, BCR and GAD protein levels rose 
irrespective of cycloheximide, indicating altered Ag levels were not due to protein 
synthesis but rather to impaired degradation of these Ags (Figure 15 B and C). 
Furthermore, transcripts for BCR and GAD were unchanged by serum 
deprivation, again pointing to perturbations in cellular protein degradation 
pathways (Figure 16 A and B).  
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Figure 15. Serum deprivation in PG cells altered expression levels of 
antigens. PG cells were cultured with (Cont.) or without serum for 6 or 12 h in the 
presence or absence of cycloheximide (CHX) prior to lysis and immunoblot 
analysis of (A) MP1, (B) GAD and (C) BCR. GAPDH was used as a loading 
control for these studies. Ag expression was normalized to GAPDH expression. 
The fold change of Ag:GAPDH for serum deprived cells was determined 
compared with the Cont. serum-treated cells. *p<0.05, **p<0.01, Multiple T-Test, 
Holm-Sidak multiple comparisons correction. Data depict results from three or 
more independent experiments, ±SEM. 
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Serum deprivation induced protease activity  
To determine if the observed disruptions of BCR and GAD degradation were due 
to alterations in endosomal and lysosomal protease levels, mRNA levels of 
several acidic proteases were assessed. Serum deprivation did not significantly 
alter AEP, or cathepsin A, B or S mRNA levels as assessed by qRT-PCR 
(Figure 17). Transcription Factor EB (TFEB) is a master regulator of lysosomal 
biogenesis and autophagy (174). Analysis by qRT-PCR revealed TFEB 
expression was significantly reduced by serum deprivation (Figure 18). During 
starvation, phosphorylation of TFEB is prevented leading to its translocation from 
the cytoplasm to the nucleus where it acts as a transcription factor (175). While 
TFEB mRNA levels appear to drop with starvation, TFEB activity may still be 
upregulated in these cells depending on the phosphorylation of this protein. 
Figure 16. Serum deprivation did not alter expression of antigen 
mRNA. PG cells were cultured with (Cont.) or without serum for 6 or  
12 h. Cells were harvested for qRT-PCR analysis. Relative expression 
of (A) GAD2 (GAD) and (B) IGKC (BCR) was determined using 
GAPDH levels. Data depict means from three independent 
experiments, ±SEM. 
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These data show mRNA expression of lysosomal proteases was unaltered by 
serum deprivation, though expression of mRNA encoding the master regulator of 
lysosomes and autophagy biogenesis was reduced during prolonged deprivation.  
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Figure 17. Serum deprivation did not significantly alter 
protease mRNA expression. PG cells were cultured with (Cont.) 
or without serum for up to 48 h. Cells were harvested for qRT-PCR 
analysis of AEP, and cathepsins (CAT)  A, B, and S. mRNA 
expression was determined relative to GAPDH mRNA levels. Data 
depict the means from three independent experiments, ±SEM. 
Figure 18. Serum deprivation altered 
TFEB mRNA expression. PG cells 
were cultured with (Cont.) or without 
serum for for up to 48 h. Cells were 
harvested for qRT-PCR analysis of the 
lysosomal gene master regulator TFEB.  
mRNA  expression was determined 
relative to GAPDH mRNA levels. 
 **p<0.01, ***p<0.001. One-way ANOVA, 
Dunnett’s multiple comparisons 
correction. Data depict the means from 
three independent experiments, ±SEM.  
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While expression of mRNAs encoding several lysosomal proteases were 
unaltered by serum deprivation, the activity of these proteases could be impaired, 
accounting for altered degradation of the BCR and GAD during serum 
deprivation. Acidification of the endosomal/lysosomal compartments is key for 
the function of multiple proteases including cathepsin B, D, S and L (176, 177). 
PG cells were cultured with or without serum for up to 12 h in the presence of 
dual-labeled FITC:rhodamine tagged dextrans. While FITC is pH sensitive and 
dims upon reaching acidic compartments, the rhodamine label is pH insensitive 
(160). This dual fluorescent-tagged probe can be used for assessing relative 
rates of endocytosis as well as endosomal/lysosomal acidification. The ratio of 
FITC:rhodamine can be used to assess acidification independent of endocytosis 
rates as FITC dims with decreasing pH. Serum deprivation significantly reduced 
the relative FITC fluorescence, indicative of lower or more acidic pH in the 
endosomal and lysosomal compartments of these cells (Figure 19).   
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Figure 19. Serum deprivation lowered 
the pH of endosomes and lysosomes. 
PG cells were cultured with or without 
serum and treated with dual-fluorescent 
labeled dextran for up to 12 h. Relative loss 
of FITC fluorescence, a pH sensitive 
fluorochrome, was assessed relative to 
rhodamine, a pH insensitive fluorochrome.  
* p<0.05, One-way ANOVA, Dunnett’s 
multiple comparisons correction. Data 
depict means from three independent 
experiments, ±SEM. 
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Acidification of the endosomal/lysosomal vesicles indicates enhanced protease 
activity. Leupeptin is a protease inhibitor known to disrupt cathepsin S and L 
degradation of Ii chain, allowing detection of the Ii chain fragments SLIP and LIP 
(16). To assess protease activity, Ii chain degradation was monitored in PG cells 
cultured with or without serum in the presence of leupeptin. Immunoblot analysis 
of Ii chain fragment LIP, revealed serum deprivation reduced the build up of LIP 
during leupeptin treatment (Figure 20). These data together with the acidification 
of endosome/lysosomes suggest greater acidic protease activity during serum 
deprivation. 
 
 
 
To further assess protease activity cathepsin B, L and H activities were 
determined in lysates from PG cells cultured with or without serum. Serum 
deprivation led to a significant increase in cathepsin B and L activity, though 
Figure 20. Serum deprivation altered invariant chain 
degradation. PG cells were cultured with (Cont.) or without 
serum for 6 or 12 h in the presence of the protease inhibitor 
leupeptin.  Cells were harvested and lysed for immunoblot 
analysis of the LIP fragment of Ii chain and GAPDH. Data 
representative of three experiments. 
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cathepsin H remained unchanged (Figure 21 A). To confirm enhanced cathepsin 
activity in serum deprived cells, a real-time flow cytometric analysis of cathepsin 
proteolysis was used. PG cells were cultured with or without serum in the 
presence of membrane soluble cathepsin substrates that fluoresce upon 
cleavage. This analysis revealed increased cathepsin B and L activity in 
response to serum deprivation (Figure 21 B and C).  
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To further assess the effect of serum deprivation on cathepsin activity, human B 
cells were isolated from peripheral blood and cultured with or without serum for 
12 h in the presence of membrane permeable cathepsin substrates. Serum 
deprivation increased cathepsin B and L activity in these freshly isolated human 
peripheral blood B cells (Figure 22 A and B).  
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Figure 22. Serum deprivation induced lysosomal 
protease activity in human peripheral blood B cells. 
Real-time analysis of cathepsin B (A) and L (B) activity in 
peripheral blood B cells cultured with (Cont.) serum or 
without serum for 12 h. Cell profile for no substrate treated 
cells is shown (gray shaded). (C) Quantitation of relative 
cathepsin activity. *p<0.05, Two-way ANOVA, Dunnett’s 
multiple comparisons correction. Data depict averages from 
three independent experiments, ±SEM. 
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GAD is processed not only in endo/lysosomes but also within the cytoplasm. 
Processing of cytosolic GAD by the proteasome is required for MHC class II 
presentation (11). To further assess protease activity in serum-deprived cells, 
proteasome activity was monitored using a chymotrypsin substrate that 
luminesces upon cleavage. Analysis revealed that, similar to cathepsin activity, 
proteasome activity was significantly enhanced during serum deprivation (Figure 
23).  Together, these data indicate serum deprivation enhances cellular protease 
activity, though this does not explain the reduced degradation of the GAD and 
BCR Ags during serum deprivation. 
 
 
 
Serum deprivation impaired trafficking of the BCR and GAD antigens 
The reduced turnover of the BCR and GAD in the presence of increased 
protease activity in these analyses point to possible alterations in the trafficking 
of these Ags during serum macronutrient depletion. The BCR is a surface protein 
complex that is constitutively internalized by endocytosis (67). To assess BCR 
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Figure 23. Proteasome activity 
was enhanced during serum 
deprivation. The chymotrypsin-like 
proteasome activity was determined 
in PG cells cultured with and without 
serum for up to 12 h using a  
luminescent substrate. * p<0.05 
One-way ANOVA followed by 
Dunnett’s multiple comparisons 
correction. Data depict means from 
three independent experiments, 
±SEM. 
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trafficking during serum deprivation, surface and total levels of the BCR were 
monitored by flow cytometry. Analysis of BCR trafficking revealed a 2-fold 
increase in BCR surface levels in B cells grown without serum (Figure 24 A). 
Total BCR expression increased with serum deprivation, along with the ratio of 
surface:total BCR expression (Figure 24 B), consistent with an accumulation the 
BCR on the cell surface. 
 
 
 
To further monitor the effect of serum deprivation on BCR trafficking, B cells were 
isolated from human peripheral blood and incubated with or without serum. 
Surface BCR distribution increased even more dramatically in peripheral blood B 
Figure 24. Surface expression of the BCR increased 
during serum deprivation. PG cells were cultured with or 
without serum for 12 h and fixed for flow analysis of (A) BCR 
surface levels (insert: relative surface levels of BCR for PG 
cells cultured without serum vs. Cont. cells indicated by the 
dotted line) or (B) total BCR levels  (insert: relative ratio of 
surface:total BCR for cells treated with no serum vs. Cont. 
cells indicated by the dotted line). *p<0.05, Student’s T-Test. 
Data representative of three or more independent experiments 
(inserts are averages from three or more independent 
experiments, ±SEM). 
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cells incubated without serum (Figure 25 A and B). These data suggest 
alterations in BCR trafficking during serum deprivation. 
 
 
  
BCR build up on the cell surface could occur due to increased expression of the 
BCR or decreased internalization. Assessment of BCR turnover indicated that 
synthesis of new BCR is not responsible for increased levels (Figure 15 C). To 
monitor fluid-phase endocytosis, PG cells were cultured with or without serum 
and treated with fluorescent labeled dextran. Flow analysis revealed that serum 
deprivation impaired internalization of dextrans, suggestive of diminished fluid-
phase endocytosis (Figure 26). The BCR is internalized via receptor-mediated 
Figure 25. Surface expression of the BCR increased 
during serum deprivation of human primary B cells.  
Human primary B cells were isolated from peripheral 
blood and cultured with or without serum for 12 h. Cells 
were then fixed for flow analysis of (A) BCR surface levels 
or permeablized for analysis of total BCR levels and 
assessment of the (B) ratio of surface:total BCR 
expression. BCR levels in Cont. serum-feed cells were 
normalized to 1 and the fold change in BCR expression 
relative to these control cells was graphed. * p<0.05, 
Student’s T-Test. Data depict averages from three 
independent experiments, ±SEM. 
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endocytosis. While reduction in fluid-phase endocytosis is suggestive of 
alterations in the endocytic pathway, monitoring the specific internalization of the 
BCR gives a more complete understanding of any alterations in BCR trafficking.  
 
 
 
To assess BCR internalization, surface proteins were biotinylated and 
internalization of biotin-labeled surface proteins was assessed (Figure 27 A). 
BCR internalization or endocytosis was significantly impaired in response to 
serum deprivation of PG cells (Figure 27 B). To further assess the effects of 
serum deprivation on endocytosis, internalization of MHC class II molecules was 
monitored. PG cells cultured without serum had reduced internalization of MHC 
class II molecules, suggestive of a more global affect of serum deprivation on 
endocytosis (Figure 27 C).  Furthermore, analysis of human primary peripheral 
blood B cells revealed a similar disruption in the endocytic pathway in cells 
Figure 26. Fluid-phase endocytosis was impaired during 
serum deprivation. PG cells were cultured with or without 
serum in the presence of rhodamine-labeled dextrans for 1, 
2, 4 or 6 h prior to flow analysis. The relative rhodamine-
dextran uptake was graphed. Data depict averages from four 
independent experiments, ±SEM.   
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cultured without serum; with reductions in internalization of the BCR, a similar 
though not statistically different trend was observed when monitoring the 
endocytosis of MHC class II molecules and transferrin receptor (TfR) (Figure 
28). These studies suggest a previously unrecognized role for serum nutrients in 
regulating BCR trafficking and global endocytosis.  
 
 
Figure 27. Internalization of the BCR and MHC class II molecules was 
impaired during serum deprivation. (A) PG surface proteins were 
biotinylated prior to incubation with or without serum to allow protein 
internalization. After incubation, remaining surface biotin was removed. Cells 
were then lysed for ELISA analysis of biotinylation of the (B) BCR and (C) MHC 
class II (MHCII). * p<0.05, *** p<0.001, Student’s T Test. Data depict averages 
from three or more independent experiments, ±SEM. 
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To further assess the effect of serum deprivation on trafficking of surface 
proteins, surface expression of the TfR and another membrane protein CD45R 
(also known as B220) were assessed. Serum deprivation led to a significant 
increase in TfR surface expression, similar to the BCR (Figure 29 A). This is 
suggestive of a global defect in receptor-mediated internalization. However, 
surface expression of CD45R was unaltered by serum deprivation (Figure 29 B). 
Unlike TfR and the BCR, CD45R does not localize within lipid rafts (178, 179). 
Together, these data indicate serum deprivation may alter lipid raft composition 
or internalization.  
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Figure 28. Internalization of the BCR was 
impaired during serum deprivation of 
primary B cells. Human primary B cell surface 
proteins were biotinylated prior to incubation 
with or without serum to allow protein 
internalization. After incubation, remaining 
surface biotin was removed. Cells were then 
lysed for ELISA analysis of biotinylation of the 
BCR, MHC class II (MHCII) and transferrin 
receptor (TfR). *** p<0.001, Two-way ANOVA  
followed by Dunnett’s multiple comparisons 
correction. Data depict averages from three 
independent experiments, ±SEM. 
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GAD is a cytoplasmic protein that can be found free within the cytoplasm or can 
be palmitoylated, leading to association with the cytoplasmic of membrane (180). 
To assess whether serum deprivation altered GAD trafficking and distribution, 
PG cells were cultured with and without serum and lysed into cytoplasmic and 
membrane fractions using ultracentrifugation. Immunoblot analysis of these 
fractions revealed GAD distribution was altered during serum deprivation. Serum 
deprived cells had reduced levels of cytoplasmic GAD and increased levels of 
membrane associated GAD (Figure 30 A and B). Together these data show 
serum deprivation alters the trafficking and subcellular distribution of endogenous 
Ags. 
 
Figure 29. Transferrin receptor 
surface expression increased 
during serum deprivation. PG 
cells were cultured with or without 
serum for 12 h prior to fixation for 
flow analysis of (A) surface 
transferrin receptor (TfR) and (B) 
surface CD45R. Student’s T-Test. 
 * p<0.05. Data representative of 3 
independent experiments, ±SEM. 
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To determine whether alterations in GAD distribution were the mechanism by 
which MHC class II presentation of GAD epitopes was disrupted by serum 
deprivation, Priess cells were transduced with a mutated form of GAD that is not 
capable of binding membranes (CytoPG) (181). CytoPG and PG cells were 
cultured with or without serum for 12 h and MHC class II presentation of an 
epitope derived from GAD was monitored. GAD presentation in CytoPG cells 
was significantly disrupted by serum deprivation, similar to wild-type GAD in PG 
cells (Figure 31). Furthermore, MHC class II presentation of a synthetic peptide 
Figure 30. Serum deprivation altered GAD subcellular 
localization. PG cells were cultured with or without serum for 12 h, 
harvested and lysed into (A) cytoplasmic and (B) membrane 
fractions using differential ultracentrifugation. Lysates were resolved 
by SDS-PAGE and immunobloted for GAD and as a loading control 
GAPDH (cytoplasmic) or MHC class II molecules (MHCII) 
(membrane). *p<0.05, Student’s T-Test. Data depict results from 
three independent experiments, ±SEM. 
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derived from GAD was unchanged by serum deprivation in both PG and CytoPG 
cells (Figure 31). These data indicate disruptions in GAD presentation during 
serum deprivation were not due to membrane attachment of GAD, but rather 
perhaps GAD association with membranes is a byproduct of disruptions in GAD 
degradation. 
 
 
 
Together these data show serum deprivation alters the degradation of 
endogenous Ags. While intracellular protease activity is enhanced, degradation 
of specific Ags is impaired. This is likely due to altered trafficking of these Ags. 
Reduced cellular endocytosis leads to disruptions in the internalization of the 
BCR, preventing its degradation. Furthermore, GAD subcellular distribution is 
altered during serum deprivation. While association with membranes is likely not 
Figure 31. Serum deprivation 
disrupted GAD presentation 
regardless of subcellular 
distribution. PG cells or priess 
cells transfected to express a 
mutated GAD that does not 
associate with membranes 
(CytoPG) were cultured with or 
without serum for 12 h, harvested, 
fixed and MHC class II presentation 
of endogenous GAD or the 
synthetic GAD peptide was 
monitored. **** p<0.0001, Two-way 
ANOVA followed by Dunnett’s 
multiple comparisons correction. 
Data represents triplicates from one 
experiment, ±SD. 
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the cause of disruptions in GAD presentation, altered subcellular distribution 
during serum deprivation indicates disruptions in the trafficking of this Ag. 
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Chapter 3. 
Exogenous macromolecules restored intracellular antigen trafficking and 
presentation during serum deprivation 
 
Serum is macronutrient rich, containing proteins, lipids and complex 
carbohydrates. Some proteins such as growth factors and cytokines may have 
potent biological activity, which could impact B cell function. Studies have shown 
that loss of specific micronutrients such as zinc can affect global immune 
responses (182). The contribution of the different components of serum to the 
growth of cells has not been well established. While serum deprivation altered 
the trafficking of Ags in B cells, studies here establish whether these alterations 
are due to reduced levels of macronutrients in general or attributed to the 
availability of a specific growth factor, protein or carbohydrate.  
 
Macronutrients restored BCR surface expression in a size dependent 
manner 
To determine the components of serum responsible for affecting B cell Ag 
trafficking, serum components were fractionated using filters with molecular mass 
cut-offs of 30 kDa and 10 kDa. PG cells were cultured with serum, without serum 
or in media supplemented with <10 kDa, <30 kDa, or the >30 kDa serum 
fractions for 12 h prior to flow cytometric analysis of surface BCR. Internalization 
of BCR was reduced with serum deprivation or upon cultivation of PG cells with 
serum components smaller than 10 kDa. However, serum fractions with higher 
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molecular mass components (>10kDa) were effective at restoring surface BCR 
levels (Figure 32). Though, studies assessing the protein concentration of these 
fractions found the >30 kDa fraction contained the majority of the protein with 
more then 30% (wt/vol) protein within the media whereas the smaller fractions 
<10 kDa and <30 kDa were between 4-6% protein as monitored by the biorad 
protein assay. This suggests a component or multiple components found within 
the high molecular mass serum fraction is capable of modulating BCR trafficking. 
 
 
 
To further elucidate the serum components responsible for altering BCR 
trafficking, the effects of supplementing serum-free media with a single protein or 
carbohydrate was assessed. Supplementation of culture media with protein BSA 
(68 kDa) or with the complex carbohydrate dextran (70 kDa) at 1% (wt/vol) was 
sufficient to normalize BCR surface levels (Figure 33). The restoration of BCR 
Figure 32. Supplementation with high 
molecular mass macronutrients 
prevented disruptions in BCR 
trafficking. (A) Serum was fractioned into 
>30 kDa, <30 kDa, and <10 kDa. PG was 
cultured for 12 h in media with or without 
serum or in media supplemented with 
these fractions. Cells were harvested and 
stained for flow cytometry analysis of 
surface BCR levels. The level of surface 
BCR on control cells cultured with media 
containing serum was normalized and set 
to 1 (depicted as dotted line). * p<0.05 
and **p<0.01, One-way ANOVA followed 
by Dunnett’s multiple comparisons 
correction. Data depict averages from 
three independent experiments, ±SEM. 
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trafficking by either BSA or dextran suggests a general role for high molecular 
mass macronutrients in regulating BCR trafficking rather than a specific nutrient. 
Furthermore, here media was supplemented at 1% (wt/vol) protein, which is less 
then the any of the serum fractions. This suggests the lower protein 
concentrations found in the smaller (<10 kDa and <30 kDa) fractions were not 
contributing factors to the alterations in BCR trafficking, further suggesting a role 
for high molecular mass macronutrients in regulating BCR trafficking. 
 
 
 
To elucidate if fatty-acids associated with BSA or if protein conformation was 
responsible for preventing disruptions in BCR trafficking, PG cells were cultured 
with serum, without serum or in serum-free media supplemented with denatured 
(boiled) or fatty-acid free BSA. Denatured or fatty acid-free BSA also restored 
surface BCR levels, suggesting protein conformation or bound fatty acids were 
not critical (Figure 34). These data further suggest BCR trafficking is regulated 
Figure 33. Exogenous macronutrients 
restored trafficking of the BCR. PG cells were 
cultured for 12 h with or without serum or in media 
supplemented with 1% (wt/vol) exogenous BSA or 
70 kDa dextran. Cells were harvested and stained 
for flow cytometry analysis of surface BCR levels. 
The level of surface BCR on control cells cultured 
with media containing serum was normalized and 
set to 1 (depicted as dotted line) and the fold 
change relative to this control graphed.  
**** p<0.0001, One-way ANOVA followed by 
Dunnett’s multiple comparisons correction. 
#p<0.05, Student’s T-Test to Cont. cells. Data 
depict averages from three independent 
experiments, ±SEM. 
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by high molecular mass macronutrients and that the biological function and 
conformation of these nutrients does not matter.  
 
 
 
Consistent with the serum fractionation, larger macromolecules or macronutrients 
were more effective at restoring surface BCR levels as shown by supplementing 
media with different sized proteins: BSA, OVA (45 kDa) or HEL (14 kDa) or 
various sized dextrans (Figures 35). This further confirms larger macronutrients, 
but not small molecular mass molecules, direct BCR trafficking. These data 
suggest B cells are capable of sensing and distinguishing extracellular 
macronutrients based on size and alter endocytic trafficking pathways based on 
macronutrient size.  
 
 
Figure 34. Fatty-acid free and boiled BSA 
prevented alterations in BCR trafficking. 
PG cells were cultured for 12 h with or 
without serum or in media supplemented with 
1% (wt/vol) exogenous fatty-acid free or 
boiled BSA. Cells were harvested and 
stained for flow cytometry analysis of surface 
BCR levels. The level of surface BCR on 
control cells cultured with media containing 
serum was normalized and set to 1 (depicted 
as dotted line) and the fold change relative to 
this control was graphed. * p<0.05, One-way 
ANOVA followed by Dunnett’s multiple 
comparisons correction. #p<0.05, Student’s 
T-Test to Cont. cells. Data depict averages 
from three independent experiments, ±SEM. 
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To determine if restoration of BCR trafficking was dependent on endocytosis or 
macropinocytosis, cells were treated with amiloride, a sodium channel inhibitor 
which disrupts these pathways (183). Macropinocytosis engulfs extracellular 
macromolecules and membrane proteins independent of clathrin (184). In APCs, 
the resulting macropinosomes ultimately fuse with mature endosomal/lysosomal 
vesicles rich in MHC class II molecules (185). Amiloride addition abrogated the 
effects of BSA in restoring BCR surface expression, suggesting macronutrient 
Figure 35. Macromolecular size influenced BCR trafficking. PG cells 
were cultured for 12 h with or without serum or in media supplemented with 
1% (A) BSA (68 kDa), ovalbumin (OVA, 45 kDa), hen-egg lysozyme (HEL, 
14 kDa) or (B) various sized dextrans (70, 40 or 10 kDa). The level of 
surface BCR on control cells cultured with media containing serum was 
normalized and set to 1 (depicted as dotted line) and the fold change 
relative to this control was graphed. *p<0.05, ** p<0.01 and *** p<0.001, 
One-way ANOVA followed by Dunnett’s multiple comparisons correction. 
#p<0.05, Student’s T-Test to Cont. cells. Data depict averages from three 
independent experiments, ±SEM. 
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normalization of BCR trafficking was dependent on macropinocytosis or 
endocytosis (Figure 36). Thus, B cell sensing of exogenous macronutrients 
effectively altered surface BCR expression by modulating endocytic pathways. 
 
 
 
Furthermore, BSA supplementation restored global defects in clathrin-mediated 
endocytosis as trafficking of TfR was restored (Figure 37 A). In contrast, BSA did 
not alter CD45R surface levels, a surface protein that is not internalized via 
endocytosis  (Figure 37 B). This suggests that B cell sensing of exogenous high 
molecular mass macronutrients such as protein affects trafficking within the cell, 
specifically trafficking through the clathrin-mediated endocytic network. 
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Figure 36. Amiloride blocked macronutrient 
restoration of BCR trafficking. PG cells were 
cultured with or without serum or in media 
supplemented with BSA for 12 h. Cells were also 
treated with or without amiloride, an inhibitor of 
macropinocytosis or endocytosis. Cells were fixed 
for flow analysis of BCR surface levels. The level of 
surface BCR in Cont. serum-fed cells was 
normalized and set to 1. BCR surface levels relative 
to this control were graphed. ****p0<.0001, One-way 
ANOVA followed by Dunnett’s multiple comparisons 
correction. #p<0.05, Student’s T-Test. Data depicts 
averages of three or more independent experiments, 
±SEM. 
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High molecular mass macronutrients restored antigen trafficking and 
presentation 
To further assess the effect of macronutrient supplementation on Ag subcellular 
distribution, trafficking of the BCR and GAD were monitored. Supplementation of 
media with BSA was sufficient to prevent disruptions in BCR internalization 
during serum deprivation (Figure 38 A). Furthermore, BSA supplementation 
prevented disruptions in MHC class II internalization (Figure 38 B).  
Figure 37. Macronutrients prevented disruptions in transferrin 
receptor trafficking. PG cells were cultured for 12 h with or without serum 
or in media supplemented with 1% BSA (68 kDa). PG cells were harvested 
and fixed for flow analysis of surface (A) TfR and (B) CD45R (B220). The 
level of surface TfR or CD45R on control cells cultured with media 
containing serum was normalized and set to 1 (depicted as dotted line) and 
the fold change relative to this control was graphed. * p<0.05, One-way 
ANOVA followed by Dunnett’s multiple comparisons correction. Data depict 
averages from three independent experiments, ±SEM. 
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These data indicate that exogenous macronutrient sensing regulates the 
endocytic network. To determine if alterations in subcellular distribution of GAD 
were caused by macronutrient sensing as well, PG cells were cultured with or 
without serum or in serum-free media supplemented with BSA for 12 h. Cells 
were lysed and cytoplasmic proteins were isolated from membrane associated 
proteins by differential ultracentrifugation. Immunoblot analysis revealed BSA 
supplementation prevented disruptions in GAD subcellular localization (Figure 
39).  Together these data show macronutrient regulation of Ag trafficking within B 
cells. 
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Figure 38. Macronutrient supplementation prevented disruptions in 
endocytosis. PG surface proteins were biotinylated prior to incubation with or 
without serum or in media supplemented with 1% BSA to allow protein 
internalization. After incubation, remaining surface biotin was removed. Cells 
were then lysed for ELISA analysis of biotinylation of the (A) BCR and (B) 
MHC class II (MHCII). * p<0.05 and *** p<0.001, One-way ANOVA followed by 
Dunnett’s multiple comparisons correction. Data depict averages from three or 
more independent experiments, ±SEM. 
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To assess the effect of macronutrients on Ag presentation, MHC class II 
presentation of epitopes derived from GAD and BCR was monitored in PG cells 
cultured with or without serum or in media supplemented with BSA. Disruptions 
in MHC class II presentation of an epitope derived from GAD during serum 
deprivation were prevented by supplementing media with BSA (Figure 40 A). 
Furthermore, BSA conformation did not contribute to prevention of disruptions in 
GAD presentation, as boiled BSA was as effective at preventing these 
disruptions as native BSA (Figure 40 A).  BSA supplementation was also 
effective at preventing disruptions in MHC class II presentation of an epitope 
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Figure 39. Macronutrient supplementation restored GAD subcellular 
localization during serum deprivation. PG cells were cultured with or without 
serum or in serum-free media supplemented with BSA for 12 h, harvested and 
lysed into (A) cytoplasmic and (B) membrane fractions using differential 
ultracentrifugation. Lysates were resolved by SDS-PAGE and immunoblotted for 
GAD and as a loading control GAPDH (cytoplasmic) or MHCII (membrane). 
*p<0.05, One-way ANOVA followed by Dunnett’s multiple comparisons correction. 
Data is representative of three independent experiments, ±SEM.  
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derived from the BCR (Figure 40 B). Supplementation of media with BSA was 
successful at preventing disruptions in MHC class II presentation, though 
supplementation with this macronutrient did not alter MHC class II surface 
expression (Figure 41). 
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Figure 40. Macronutrients prevented disruptions in MHC class II 
antigen presentation during serum deprivation. PG cells were cultured 
for 12 h with or without serum or in media supplemented with 1% BSA (68 
kDa) or boiled BSA. MHC class II presentation of an epitope derived from 
(A) GAD and (B) BCR were monitored. ***p<0.001 and  ****p<0.0001, One-
way ANOVA followed by Sidak’s multiple comparisons correction. Data 
depict means from three or more independent experiments, ±SEM.  
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) Figure 41. Macronutrient supplementation 
did not alter MHC class II surface levels. PG 
cells cultured with or without serum or in media 
supplemented with 1% BSA for 12 h. Cells were 
harvested and stained for flow cytometry 
analysis of surface MHC class II molecules. 
One-way ANOVA followed by Dunnett’s multiple 
comparisons. Data depict MFI from three 
independent experiments, ±SEM.   
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To determine the concentration of BSA necessary for restoring MHC class II 
presentation, PG cells were cultured with various concentrations of BSA and 
MHC class II presentation of epitopes derived from the GAD Ag was assessed 
(Figure 42). Here, BSA supplementation at levels as low as 0.01% were capable 
of preventing disruptions in GAD presentation. This suggests low levels of 
macronutrients restore Ag trafficking through this pathway. 
 
 
 
To examine if macronutrient deprivation globally regulates Ag endocytosis, MHC 
class II presentation of another membrane Ag that utilizes clathrin-mediated 
endocytosis was assessed. Similar to the BCR, MHC class II presentation of an 
epitope derived from the constitutively expressed MHC class I membrane protein 
was significantly impaired by serum deprivation and BSA supplementation 
partially prevented this disruption (Figure 43 A). Interestingly, surface expression 
of MHC class I was unaltered by serum deprivation (Figure 43 B). While serum 
deprivation enhanced surface expression of the BCR, MHC class I and MHC 
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Figure 42. Low concentrations of 
macronutrients prevented disruptions in 
MHC class II antigen presentation during 
serum deprivation. PG cells were cultured for 
12 h with or without serum or in media 
supplemented with various concentrations of 
BSA (68 kDa) and MHC class II presentation of 
an epitope derived from GAD was monitored. 
*p<0.05 **p<0.01 and ***p<0.001, One-way 
ANOVA followed by Tukey’s multiple 
comparisons correction. Data is representative 
of 3 independent experiments, ±SD.  
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class II surface expression were unaltered (Figure 9). Studies assessing the 
specific internalization of MHC class II did reveal reduced endocytosis of this 
protein during serum deprivation (Figure 27 and 28), suggesting altered 
trafficking of this protein even though surface expression remains unaltered.  
 
 
 
At this low level, macronutrient supplementation did not prevent the 
induction of macroautophagy or protease activity 
Macronutrient supplementation prevented disruptions in BCR and GAD Ag 
trafficking. To assess whether supplementation with macronutrients also 
prevented alterations in MA pathway and protease activity with serum 
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Figure 43. Macronutrient deprivation disrupted MHC class II 
presentation of an epitope derived from the MHC class I 
membrane antigen. PG cells were cultured for 12 h with or without 
serum or in media supplemented with 1% BSA (68 kDa). (A) MHC 
class II presentation of an epitope derived from MHC class I (MHCI) 
was monitored or (B) cells were fixed for flow analysis of surface 
MHCI and the relative MFI graphed. *p<0.05, One-way ANOVA 
followed by Dunnett’s multiple comparisons correction. Data depict 
means from three or more independent experiments, ±SEM.  
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deprivation, PG cells were cultured with or without serum or in media 
supplemented with BSA prior to analysis of MA flux or protease activity. MA flux 
remained elevated in BSA treated cells, indicating macronutrient 
supplementation at this concentration did not prevent induction of the MA 
pathway (Figure 44). Consistent with MA remaining elevated with BSA 
supplementation, MHC class II presentation of an epitope derived from the MA 
targeted MP1 Ag remained elevated with BSA supplementation (Figure 45). This 
suggests the MA pathway is more sensitive to macronutrient deprivation than the 
endocytic and CMA pathways, as these pathways were restored at this low 
concentration of BSA. 
 
 
Figure 44. Macroautophagy remained elevated in 
macronutrient supplemented cells. PG cells were cultured 
with (Cont.) or without serum  for 12 h in the presence or 
absence of chloroquine (CQ), harvested and lysed for 
immunoblot analysis of LC3II expression.  LC3II expression 
was compared to Cont. cells and GAPDH was used as a 
loading control. (B) To quantitate macroautophagy flux, LC3II 
protein levels were normalized to the loading control GAPDH. 
LC3II:GAPDH basal levels were subtracted from the those 
seen in CQ treated cells for each treatment. The level of MA 
flux in serum-treated cells was normalized to 1 and used as a 
control (dotted line). Fold change relative to this control was 
graphed for cells cultured in serum-free media or with BSA. 
*p<0.05, Student’s T-Test to Cont. cells. Data depict MA flux 
from three independent experiments, ±SEM.  
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To further assess the effect of macronutrients on the endosomal network, 
protease activity was monitored in cells cultured with BSA. BSA and dextran 
supplementation did not prevent induction of lysosomal protease activity as seen 
by elevated cathepsin B and L activity in PG cells cultured in media 
supplemented with these macromolecules (Figure 46). 
 
 
Co
nt.
No
 Se
ru
m
BS
A
0.0
0.5
1.0
1.5
2.0
R
el
at
iv
e 
T 
ce
ll 
ac
tiv
at
io
n MP1 Epitope Figure 45. MP1 antigen presentation 
remained elevated in macronutrient 
supplemented cells. PG cells were cultured for 
12 h with or without serum or in media 
supplemented with 1% BSA (68 kDa) prior to 
fixation and detection of MHC class II 
presentation of an epitope derived from the MA 
targeted MP1 Ag. Data depict means from three 
independent experiments, ±SEM.  
Figure 46. Cathepsin activity remained elevated during 
macronutrient supplementation. (A and B) Real-time analysis of 
cathepsin B and L activity in PG cells cultured with or without 
serum or in media supplemented with 1% BSA or dextran for 12 h.  
***p<0.001, One-way ANOVA, Dunnett’s multiple comparisons 
correction. Data depict averages from three independent 
experiments, ±SEM.   
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Serum deprivation appeared to alter the phenotype of B cells. During serum 
deprivation, the normally suspended PG cells settled onto the plate as observed 
by monitoring the media and light microscopy, though macronutrient 
supplementation did not prevent this change in phenotype (Figure 47 A). A 
similar adherence of peripheral blood B cells was observed with serum 
deprivation. Altering the protein and lipid composition of the media may result in 
changes in osmolarity and viscosity, both of which may affect cell biology. To 
assess this, the osmolarity and viscosity of IMDM media alone or supplemented 
with BSA, dextran or serum was determined (Figure 47 B). These data indicate 
serum, dextran and BSA did not significantly alter osmolarity or viscosity of IMDM 
media. Furthermore, the different macronutrient supplementations did not affect 
the pH of the media, with the pH of the control media with serum, serum-free 
media and BSA supplemented media ranging from 7.2 to 7.3. Furthermore, 
electron microscopy revealed no significant alterations in cell phenotype (Figure 
48).  
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A 
B 
Figure 47. Serum deprivation altered the phenotype 
of B cells. (A) Picture of PG cells cultured with or without 
serum for 12 h. Cells cultured with serum grew in clusters 
in suspension, whereas serum-deprived and BSA-fed 
cells settled onto the flask surfaces. The (B) osmolarity 
and (C) viscosity of culture media alone or containing 
serum, BSA or dextran. !
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Together, these data indicate that B cell sensing of macronutrients regulates Ag 
trafficking, affecting in some cases the steady-state subcellular localization of 
these proteins. Furthermore, these alterations in trafficking impact the availability 
of epitopes derived from these Ags, altering MHC class II presentation. While 
supplementation with a single macronutrient such as protein was sufficient to 
restore Ag trafficking and MHC class II Ag presentation, this was dependent on 
the molecular mass of the macronutrient. Supplementation with smaller 
macronutrients was not able to fully restore Ag trafficking, while supplementation 
with larger (>70 kDa) macronutrients fully averted alterations in Ag trafficking and 
presentation observed in serum deprived cells. In contrast, these low levels of 
macronutrient supplementation did not prevent the induction of MA nor cathepsin 
activity suggesting these alterations are more sensitive to macronutrient 
deprivation.  
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Chapter 4. 
A role for HSC70 in antigen trafficking during macronutrient deprivation 
 
While GAD and the BCR reach the endocytic pathway by seemingly disparate 
pathways, macronutrient deprivation altered their trafficking, degradation and 
MHC class II presentation in some similar ways. These data suggest a common 
link between these pathways may exist which could be altered by macronutrient 
deprivation. 
 
HSC70 is a conserved chaperone found in the cytoplasm as well as the lumen of 
lysosomes. HSC70 plays a role in several pathways linked to protein folding and 
transport within cells, contributing to cell homeostasis. Studies have revealed 
HSC70 is required for endocytosis, chaperoning clathrin and providing the 
energy necessary to assemble and disassemble the clathrin coat (76, 109). This 
suggests HSC70 may be required for BCR trafficking via endocytosis. 
Furthermore, HSC70 is known to chaperone proteins to the lysosomal membrane 
for translocation in the selective form of autophagy, CMA (106). Our laboratory 
has shown HSC70 is required for MHC class II presentation of the cytoplasmic 
GAD Ag, through the CMA pathway (78). Together, these studies indicate that 
the Ag processing pathways for the BCR and GAD may share a requirement for 
the chaperone HSC70. Studies in this chapter demonstrate a role for HSC70 in 
Ag trafficking and presentation during macronutrient deprivation. 
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Macronutrient deprivation did not alter HSP protein expression 
HSC70 is required for both endocytosis and CMA, the pathways required for 
BCR and GAD presentation by MHCII, respectively. To assess whether 
macronutrient deprivation altered HSC70 expression, PG cells were cultured with 
or without serum for up to 48 h. PG cells were harvested and mRNA expression 
was monitored. Expression of HSC70 (HSPA8) mRNA was not significantly 
altered during serum deprivation although an initial trend towards increase in this 
mRNA was detected in the first 12 h of starvation (Figure 49). HSP90, another 
constitutively expressed HSP found in both the cytoplasm as well as the lumen of 
lysosomes, is also required for GAD presentation and can interact with HSC70 in 
the cytoplasm (97, 123). Here, mRNA expression of the cytoplasmic HSP90 
isoforms, HSP90α (HSP90AA) and HSP90β (HSP90AB), were monitored in PG 
cells. Although extended periods of serum deprivation led to a significant drop in 
HSP90AA, short periods (up to 12 h) did not significantly alter the expression of 
these mRNAs, though there was a trend towards higher HSP90AB during early 
time points  (Figure 49). 
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To further assess HSC70 expression during macronutrient deprivation, HSC70 
protein levels were monitored in PG cells cultured with or without serum or in 
media supplemented with BSA for 12 h. HSC70 protein levels remained constant 
in these cells regardless of the availability of macronutrients (Figure 50). 
Furthermore, HSP90 protein expression was unaltered by serum deprivation 
(Figure 51). 
 
Figure 49. Macronutrient deprivation for up to 24 h did not alter HSC70 
and HSP90 mRNA expression. PG cells were cultured with serum (Cont.) 
or without serum for 6, 12, 24 or 48 h. Cells were harvested, mRNA isolated 
and cDNA synthesized for qRT-PCR analysis of HSPA8 (HSC70), HSP90AA 
(HSP90a) and HSP90AB (HSP90b). *p<0.05, Two-way ANOVA followed by 
Holme’s Sidak comparisons correction. Data depict averages from three 
independent experiments, ±SEM.  
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HSC70 is a cytosolic protein that can be found in the cytoplasm and on the 
surface of membranes including autophagosomes. To assess whether 
macronutrient deprivation altered the location of HSC70, PG cells were cultured 
with or without serum for 12 h prior to separation of cytosolic from membrane 
associated fractions. Immunoblot analysis of these different subcellular fractions 
Figure 50. Macronutrient deprivation did not alter HSC70 
protein expression. PG cells were cultured with serum (Cont.), 
without serum or in serum-free media supplemented with BSA for 
12 h. (A) Cells were harvested and lysed for immunoblot analysis 
of HSC70. (B) Densitometry was used to quantitate relative levels 
of HSC70 to GAPDH. Data representative of three independent 
experiments, ±SEM.  
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Figure 51. Macronutrient deprivation 
did not alter HSP90 protein expression. 
PG cells were cultured with serum (Cont.) 
or without serum for 12 h. Cells were 
harvested and lysed for immunoblot 
analysis of HSP90 and GAPDH. Data 
representative of three independent 
experiments.  
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revealed HSC70 distribution on membranes was not altered by serum 
deprivation (Figure 52).  
 
 
 
Macronutrient deprivation impaired HSC70 association with cytoplasmic 
GAD antigen 
To assess whether serum deprivation altered HSC70 activity, GAD association 
with HSC70 was monitored in PG cells cultured with or without serum or in media 
supplemented with BSA. While GAD associated with HSC70 in control serum-
treated cells and BSA supplemented cells at similar levels, macronutrient 
deprivation significantly reduced the association of GAD and HSC70 (Figure 53). 
Figure 52. HSC70 subcellular distribution was unaltered by 
macronutrient deprivation. PG cells were cultured with or without 
serum for 12 h, harvested and lysed into (A) cytoplasmic and 
membrane fractions using differential ultracentrifugation. Lysates 
were resolved by SDS-PAGE and immunoblotted for HSC70 and as 
a loading control GAPDH (cytoplasmic) or MHC class II (MHCII) 
(membrane). (B) Densitometry was used to quantitate the ratio of 
HSC70 to GAPDH or MHC class II. Data depict results from three 
independent experiments, ±SEM.  
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These data suggest macronutrient deprivation may alter the accessibility and 
function of HSC70. 
 
 
 
As HSC70 is vital for the CMA pathway, the functional activity of this pathway 
was assessed. LAMP2A is the transmembrane protein found on lysosomes that 
assists in the translocation of proteins during CMA. Studies have suggested 
LAMP2A is the limiting factor regulating CMA, with reduced levels of LAMP2A 
diminishing CMA activity (186). LAMP2 protein levels were assessed during 
macronutrient deprivation. LAMP2 protein levels rose during early stages of 
serum deprivation (Figure 54). Importantly, the LAMP2 Ab detects not only 
LAMP2A but also the LAMP2B and LAMP2C isoforms. LAMP2B is involved in 
Figure 53. Macronutrient deprivation altered HSC70 association 
with GAD. PG cells were cultured with or without serum or in serum-
free media supplemented with BSA for 12 h. Cells were harvested and 
lysed for immunoprecipitation of GAD. GAD and associated proteins 
were resolved by SDS-PAGE and (A) HSC70 or as a loading control 
GAD were detected by immunoblot. (B) HSC70 levels were quantitated 
using densitometry and relative levels of HSC70 to GAD were graphed. 
Data depict results from three independent experiments, ±SEM.  
 **p<0.01, One-way ANOVA followed by Dunnett’s multiple comparisons 
correction. 
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lysosome fusions and may be important for MA (187). The function of LAMP2C 
has not been well described, though it may be involved in translocation of RNA 
from the cytosol to the lysosome in a form of RNAphagy (166). To distinguish 
changes in the expression of these different LAMP2 isoforms, the mRNA levels 
of each was assessed. No significant differences were observed in the three 
isoforms at these early time points of macronutrient deprivation (Figure 8). 
Together these data suggest that the expression of LAMP2 isoforms was not 
decreased or limiting and would not contribute to impaired CMA during serum 
deprivation.  
 
 
 
To further monitor the effect of macronutrient deprivation on the CMA pathway, 
CMA translocation of a biotin-labeled peptide was monitored. PG cells were 
Figure 54. LAMP2 protein expression increased during 
serum deprivation. PG cells were cultured without serum for 
up to 48 h or with serum as a Cont. Cells were harvested and 
lysed for immunoblot analysis of LAMP2 and GAPDH protein 
levels. The ratio of LAMP2:GAPDH was graphed for three 
independent experiments, ±SEM. *p<0.05, One-way ANOVA 
followed by Dunnett’s multiple comparisons correction.  
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incubated with a biotin-labeled GAD peptide followed by electroporation to deliver 
the peptide into the cytosol of the cell. CMA translocation of this peptide from the 
cytoplasm to lysosomal and endosomal compartments was monitored by 
assessing MHC class II association with the electroporated peptide. Serum 
deprivation did not impede MHC class II association with the peptide, suggesting 
CMA translocation of this peptide was intact (Figure 55). Given this assay tracks 
the translocation of peptide rather than intact Ag, HSC70 may not be required. 
While not definitive, this study suggests the translocation steps of CMA were not 
perturbed by serum deprivation. This may indicate the defects in Ag trafficking by 
CMA are linked to the chaperone role of HSC70. 
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Ectopic expression of HSC70 overcame the effects of macronutrient 
deprivation in B cells 
To further assess the availability of HSC70 during serum deprivation, PG cells 
were transduced to ectopically express higher levels of cytoplasmic HSC70 
(PG70). HSC70 transcript and protein levels were elevated in PG70 cells as 
compared to the PG parent cells (Figure 56).  
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Figure 55. CMA translocation of GAD 
peptide was not impaired by 
macronutrient deprivation. (A) Diagram 
of the assay. PG cells were washed in ice 
cold HBSS and 20 uM Biotin-GAD 
peptide added to solution. Cells were 
electroporated to transfer the peptide to 
the cytoplasm or, as a control, not 
electroporated. Cells were washed and 
acid striped to remove any exogenous 
peptide or peptide bound to surface MHC 
class II molecules. Cells were incubated 
with or without serum for 16 h, harvested 
and lysed for (B) immunoblot analysis of 
biotin-GAD:MHC class II complexes. Data 
representative of three or more 
experiments. 
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As macronutrient deprivation impaired HSC70:GAD interactions (Figure 53), the 
effect of ectopic HSC70 expression on this molecular interaction was assessed 
during serum deprivation. PG70 cells were cultured with or without serum for 12 
h and GAD protein was immunoprecipitated. Here, ectopic expression of HSC70 
restored GAD association with HSC70 during macronutrient deprivation to levels 
seen in cells without this stress (Figure 57). These data suggest serum 
deprivation limits the availability of HSC70 to associate with GAD, as 
overexpression of this chaperone restored this interaction. 
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Figure 56. Ectopic expression of HSC70. PG cells 
were transfected with a vector encoding sense human 
HSC70 cDNA. PG (control) and PG70 (ectopic HSC70) 
cells were harvested and (A) HSC70 mRNA expression 
monitored by qRT-PCR (relative to GAPDH) or (B) cells 
were lysed for immunoblot analysis of HSC70 and 
GAPDH. Graphs show HSC70 relative to GAPDH from 
three independent experiments, ±SEM. * p<0.05, 
Student’s t-test.  
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To further assess the effect of HSC70 on Ag trafficking during macronutrient 
deprivation, GAD and BCR subcellular distribution was assessed in cells 
ectopically expressing HSC70. PG and PG70 cells were cultured for 12 h with or 
without serum prior to lysis and separation of proteins into cytoplasmic and 
membrane fractions. Ectopic expression of HSC70 prevented disruptions in GAD 
trafficking observed during serum deprivation (Figure 58).  Furthermore, ectopic 
HSC70 expression restored the trafficking of BCR as seen by the normalization 
of surface BCR expression (Figure 59). Restoration of Ag trafficking with 
increased HSC70 expression in B cells demonstrates a key role for this 
chaperone in modulating cellular stress and intracellular protein transport. 
HSC70&
GAD&
Con
t.&
No
&Se
rum
&
IP5GAD&
A" B"
Figure 57. Ectopic expression of HSC70 overcame disruptions in 
HSC70:GAD association during macronutrient deprivation. PG70 or as 
a control the parent cell line PG were cultured with or without serum for 12 
h. Cells were harvested and lysed for immunoprecipitation of GAD. GAD 
and associated proteins were resolved by SDS-PAGE and (A) HSC70 
detected by immunoblot. (B) HSC70 levels were quantitated using 
densitometry and relative levels of HSC70 to GAD was graphed. *p<0.05, 
Student’s T-Test followed by Holm-Sidak’s multiple comparisons correction. 
Data depict results from three independent experiments, ±SEM.  
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Figure 58. Ectopic 
expression of HSC70 
prevented disruptions in 
GAD trafficking during 
macronutrient deprivation. 
PG and PG70 cells were 
cultured with or without serum 
for 12 h, harvested and lysed 
into cytoplasmic and  
membrane fractions using 
differential ultracentrifugation. 
(A) Lysates were resolved by 
SDS-PAGE and immunobloted 
for GAD and as a loading 
control GAPDH (cytoplasmic) 
or MHCII (membrane). 
Densitometric analysis of GAD 
protein expression relative to 
(B) GAPDH or (C) MHC class II 
(MHCII). *p<0.05, Student’s T-
Test followed by Holm-Sidak’s 
multiple comparisons 
correction. Data are 
representative of three 
independent experiments, 
±SEM.  
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Figure 59. Ectopic expression of HSC70 
prevented disruptions in BCR trafficking 
during macronutrient deprivation. PG and 
PG70 cells were cultured with or without serum 
for 12 h and fixed for flow analysis of the BCR 
surface levels. Relative surface levels of BCR 
for PG cells cultured with serum (Cont.)  were 
normalized and set to one. The BCR surface 
expression relative to this control was graphed. 
*p<0.05, Two-way ANOVA followed by Sidak’s 
multiple comparisons correction. Data 
representative of three independent 
experiments, ±SEM.  
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To further assess the role of ectopic expression of HSC70 on MHC class II Ag 
presentation, the levels of MHC class II components was monitored. Ectopic 
expression of HSC70 did not alter surface expression of MHC class II molecules 
nor surface levels of CLIP:MHC class II complexes, suggesting equivalent levels 
of DM activity in these cells (Figure 60 A). Additionally, total cellular expression 
of MHC class II molecules and Ii chain were unaltered by ectopic expression of 
HSC70 (Figure 60 B and C).  
 
 
 
As ectopic expression of HSC70 restored Ag trafficking, the effect of increased 
HSC70 on MHC class II Ag presentation was assessed. As compared to control 
cells, ectopic expression of HSC70 prevented disruptions in MHC class II 
presentation of epitopes derived from GAD, the BCR and MHC class I molecules 
during macronutrient deprivation (Figure 61 A-C). Interestingly, overexpression 
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Figure 60. Ectopic expression of HSC70 did not alter MHC class II 
components. PG and PG70 cells were harvested and (A) surface expression 
of MHC class II and CLIP:MHC class II complexes were monitored or after 
fixation cells were permeablized for assessment of (B) total MHC class II 
expression by flow cytometry.  (C) PG and PG70 cells were lysed for 
immunoblot analysis of Ii chain and GAPDH as a loading control. Data 
representative of 3 or more independent experiments, ±SEM.  
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of HSC70 also reversed the enhanced MHC class II presentation of epitopes 
derived from the MP1 Ag during macronutrient deprivation (Figure 61 D).  
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Figure 61. Ectopic expression of HSC70 prevented disruptions in 
MHC class II presentation of epitopes during macronutrient 
deprivation. PG and PG70 cells were cultured with or without serum for 
12 h, harvested and fixed for analysis of MHC class II presentation of 
epitopes derived from (A) GAD, (B) the BCR, (C) MHC class I and (D) 
MP1. *p<.05, Two-way ANOVA followed by Sidak’s multiple comparisons 
correction. Data depict means from three independent experiments, 
±SEM.  
B"A"
Co
nt.12
 h
Co
nt.12
 h
0.0
0.5
1.0
1.5
2.0
T 
ce
ll 
ac
tiv
at
io
n
MP1 Epitope
PG PG70
Co
nt.12
 h
Co
nt.12
 h
0.0
0.5
1.0
1.5
T 
ce
ll 
ac
tiv
at
io
n
MHCI Epitope
PG PG70
C" D"
 110 
 
As MP1 gains access to the endosomal network through MA, MA flux was 
monitored in these cells. Consistent with MP1 presentation, MA was induced in 
serum deprived PG cells and in PG cells cultured in media supplemented with 
BSA, though ectopic expression of HSC70 prevented this induction during serum 
deprivation (Figure 62). Together, these data suggest HSC70 availability may 
regulate MA during cell stress. 
 
 
 
Overall, ectopic HSC70 expression in B cells prevented disruptions in Ag 
trafficking and presentation during macronutrient deprivation, demonstrating a 
key role for this chaperone in modulating cellular stress and intracellular protein 
transport. Here, ectopic expression of HSC70 prevented disruptions in several 
Ag trafficking pathways observed during macronutrient deprivation.  While 
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Figure 62. Ectopic expression of 
HSC70 prevented macroautophagy 
induction during serum deprivation. 
PG and PG70 cells were cultured with 
(Cont.) or without serum or in media 
supplemented with BSA for 12 h in the 
presence or absence of CQ to block 
lysosomal acidification and LC3II 
degradation. Cells were harvested, and 
lysed for immunoblot analysis of LC3II 
expression. To quantitate MA flux, LC3II 
levels were normalized to the loading 
control GAPDH and LC3II:GAPDH basal 
levels were subtracted from the induced 
CQ treated levels. MA flux in Cont. cells 
was normalized to 1 and fold change 
relative to this control graphed. Data 
depict MA flux from 3 independent 
experiments, ±SEM.  
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macronutrient deprivation did not significantly affect total cellular HSC70 levels, 
the role of HSC70 in several pathways including its participation in GAD 
translocation via CMA were significantly disrupted. Ectopic expression to 
increase cellular HSC70 levels was sufficient to prevent these disruptions, 
suggesting the availability of this shared chaperone is limiting during nutrient 
deprivation.  
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Discussion 
While it has been known for decades that protein malnourished individuals have 
a reduced capacity to mount immune responses and are therefore more 
susceptible to infection, the exact mechanisms that govern this immune 
deficiency are still unclear (140). Multiple mechanisms likely contribute to 
compromised adaptive immune responses in malnourished individuals (142, 
188). For example, zinc deficiency is linked to protein malnourishment and can 
impair T cell responses, suggesting a role for this micronutrient in regulating host 
immunity (138, 182). The studies presented here are the first to demonstrate 
protein malnourishment directly impacts MHC class II Ag presentation, a pathway 
critical for activation of both T and B cells. This study revealed a novel link 
between exogenous macronutrient levels and Ag trafficking in B cells, offering a 
previously unrecognized explanation for reduced Ab responses and impaired T 
cell mediated immunity observed in protein malnourished individuals (141).  
 
Macronutrient deprivation altered MHC class II antigen presentation 
In the current study, macronutrient deprivation was shown to directly impact 
epitope selection and MHC class II Ag presentation. During prolonged periods of 
starvation, expression of several MHC class II pathway components was 
reduced, potentially contributing to altered MHC class II Ag presentation. This 
suggests that prolonged malnutrition may alter the immune response by 
disrupting expression of immune receptors. While expression of MHC class II 
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pathway components was unaltered during short periods of starvation (up to 12 
h), MHC class II Ag presentation was impacted (Figure 63). While a study 
assessing MHC class II presentation using cells cultured in buffered saline as a 
model of extreme starvation has shown altered epitope selection, the current 
data are the first to show altered MHC class II presentation specifically in 
response to macronutrients (145). These data suggest that even short periods of 
protein malnourishment may alter the MHC class II presentation pathway 
impairing the immune response.  
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Macronutrient deprivation altered the trafficking of proteins through the 
endocytic network and antigen presentation 
While macronutrient deprivation led to a significant increase in cellular protease 
activity, degradation of both the cytoplasmic Ag GAD and the BCR was impaired. 
Impaired degradation of these Ags was likely caused by compromised protein 
trafficking during macronutrient deprivation. While exogenous macronutrients 
were able to fully prevent these disruptions in endocytic trafficking and Ag 
presentation, protease activity remained elevated, further suggesting protease 
activity was not responsible for altered MHC class II Ag presentation. 
Interestingly, macronutrient deprivation significantly disrupted clathrin-mediated 
endocytosis, impairing internalization of not only the BCR but also MHC class II 
molecules and TfR. Studies have revealed that protein deprivation reduces the 
capacity of macrophages to phagocytose bacteria in vivo and in non-immune 
cells disrupts TfR endocytosis, which indicates more global affects of nutritional 
stress on vesicular sorting (149, 189).  
 
MA and clathrin-mediated endocytosis share several key chaperones including 
HSC70, mAtg9, TBC1D5 and AP2, suggesting potential coordinate regulation of 
these intracellular transport pathways (149, 190, 191). Furthermore, the 
regulation of CMA and MA appear linked, as it is often observed that induction of 
one of these pathways occurs at the expense of the other (85, 192, 193). For 
example, during serum deprivation MA is induced during the initial 24 hr; then as 
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MA wanes, CMA is induced (106, 163, 194). The data presented here further 
suggest coordinate regulation of these Ag trafficking pathways during nutritional 
cell stress.  
 
If these pathways are coordinately regulated, other mechanisms, such as 
pharmacological activators and inhibitors that alter one pathway may influence 
the efficacy of other pathways as well. Consistent with this, the pharmacological 
agent rapamycin, which acts to promote MA by inhibiting mTOR, has also been 
shown to impair receptor-mediated endocytosis and macropinocytosis in 
dendritic cells (195). The studies presented here using Torin1 and T. gondii to 
induce MA, suggest exposing B lymphocytes to these agents may also regulate 
other components of the MHC class II pathway. Studies here are the first to 
demonstrate T. gondii infects B cells. Consistent with the observed 
downregulation of MHC class II during T. gondii infection of B cells, studies 
assessing T. gondii infection of glioblastoma and microglia cells have shown 
expression of the master regulator of MHC class II components, CIITA, is 
disrupted (196). Together, these studies indicate T. gondii disrupts the MHC 
class II presentation pathway, likely to avoid detection by the immune response.  
Furthermore, the studies presented here indicate treatment with Torin1 reduces 
CLIP:MHC class II surface complexes, suggesting Torin1 affects DM function. 
Studies further assessing the effect of Torin1 on DM function and expression 
would provide more insight into the mechanisms by which Torin1 regulates MHC 
class II Ag presentation. Together these studies suggest mechanisms used to 
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modulate MA can affect not only Ag trafficking through the endocytic network but 
also MHC class II pathway components. 
 
Our studies indicate B cells are capable of sensing macronutrient size, as 
supplementing media with small proteins or dextrans did not restore BCR 
trafficking, in contrast with large molecular mass macronutrients. This is the first 
study to suggest APCs sense nutrient size and modulate endocytic trafficking in 
response. In agreement with this observation, a recent publication has shown 
neutrophils sense the size of microbes and selectively release extracellular traps 
in response only to large microbes (197).  Together these data suggest immune 
cells sense particulate size and modulate activity based on the molecular 
dimensions of the stimuli. 
 
Accessibility of the conserved chaperone HSC70 was altered by 
macronutrient deprivation 
The current study reveals a novel role for HSC70 in controlling trafficking 
pathways during macronutrient stress of B lymphocytes. HSC70 is a 
constitutively expressed chaperone critical for clathrin-mediated endocytosis, 
proteasome degradation and the selective capture of proteins for translocation 
into lysosomes via CMA (108, 127). HSC70 guided transit of proteins to the 
proteasome and CMA appears widely conserved in neural cells as well as 
immune cells (11, 78, 85, 113). Studies from our laboratory have previously 
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demonstrated HSC70 binds to select proteins such as GAD Ag, delivering them 
for proteolytic processing and MHC class II presentation (11, 78). Furthermore, in 
fibroblasts, HSC70 association with autophagosomes may play a role in the 
clearance of cytoplasmic protein aggregate complexes by MA (198, 199). 
Intracellular competition for HSC70 was recently observed, as induction of MA by 
protein aggregates depleted chaperone reserves impairing clathrin-mediated 
endocytosis (199). The data presented here indicate during macronutrient stress 
in B lymphocytes, these trafficking pathways compete for conserved chaperones 
such as HSC70, with upregulation of MA and proteasome activity at the expense 
of endocytosis and CMA (Figure 64). This may favor the presentation of 
intracellular pathogens or self Ags sequestered in autophagosomes, while 
limiting immune recognition of endocytosed Ags. While HSC70 accessibility is 
limited during macronutrient deprivation, low levels of macronutrients could 
prevent disruptions in both endocytosis and CMA (Figure 64). MA remained 
elevated in cells supplemented with low levels of macronutrients, suggesting MA 
is more sensitive to loss of macronutrients than endocytosis and CMA (Figure 
64). Thus, HSC70 plays a key role selectively regulating endocytosis and 
autophagy during nutritional stress, impacting MHC class II Ag presentation and 
B-T cell interactions. 
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Interestingly, cells ectopically expressing HSC70 failed to induce MA during 
macronutrient deprivation. While studies have linked HSC70 to autophagosomes 
and selective autophagy, this is the first study to suggest HSC70 accessibility 
may regulate MA (198, 199). These studies suggest during nutrient stress 
HSC70 sequestration may trigger MA, whereas overexpression of this protein 
prevents induction of this pathway. 
 
Future Challenges 
The work presented here indicates macronutrient deprivation severely disrupts 
trafficking pathways within B cells. While this work has shown macronutrient 
deprivation limits the availability of HSC70 altering Ag trafficking pathways, 
further studies addressing the affect of malnourishment in vivo, the crosstalk 
between trafficking pathways, and the mechanisms that regulate HSC70 and its 
role in MA are of interest. 
 
The effect of macronutrient deprivation on APCs in vivo 
Studies here point to the exquisite sensitivity of lymphocytes to nutrient stress. 
Studies are needed to assess the effect of protein malnutrition on APCs in vivo. 
While studies have shown the levels of APCs are largely unaltered in 
malnourished individuals, the ability of these cells to expand and mount immune 
responses to infection is reduced in these individuals (142).  Here, studies 
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indicate macronutrient deprivation alters the ability of these cells to function, 
however low levels of high molecular weight protein or carbohydrate can prevent 
these disruptions. Blood contains numerous proteins. Even in protein 
malnourished individuals the protein content of blood is above 1% (wt/vol) (200). 
Our studies indicate supplementing media with 1% BSA could fully prevent 
alterations in MHC class II Ag presentation. Importantly, B cells and other APCs 
not only circulate through the blood but also through the lymphatic system where 
protein levels can be 1/6th that of those in plasma of healthy individuals (201, 
202). Furthermore, studies in canines have revealed the concentration of protein 
in the lymph drops significantly faster than protein concentration in the plasma 
increasing the discrepancies in the protein concentration between these two 
fluids (203). Together these data suggest a need for studies of lymphatic protein 
and macronutrient levels in malnourished individuals. Our studies indicate BCR 
trafficking and MHC class II protein levels may be disrupted in malnourished 
individuals. Assessing BCR and MHC class II surface levels on APCs derived 
from malnourished individuals will provide insight into the effect of malnutrition on 
these pathways in vivo. As a preliminary study into the feasibility of this approach 
in human subjects, BCR surface expression was monitored on human primary 
peripheral blood B cells isolated from 5 different individuals (Figure 65). These 
data show all five individuals had relatively similar BCR surface expression, 
indicating it may be possible to detect alterations in surface expression of this 
molecule in malnourished individuals. While these studies will provide information 
on BCR trafficking in malnourished individuals, to further elucidate the effect of 
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protein malnourishment on Ag trafficking, development of a rodent model will be 
necessary. Several studies have been published assessing the effect of altering 
the ratio of macronutrients in a rodents diet on the development of autoimmune 
disorders (204, 205). These studies indicate autoimmune disease progression 
and development are dependent on diet macronutrient levels, consistent with 
altered immune responses in these animals. Whether altering the rodents diet 
affects Ag trafficking in APCs contributing to altered immune responses was not 
assessed. Future studies could assess the effect of protein malnutrition on APCs 
by feeding rodents low protein diets and isolating APCs from these mice and 
monitoring the characteristics of surface proteins as well as their ability to present 
Ags and activate T cells.   
 
 
 
 122 
 
Cross-talk among the endocytic, macroautophagy and chaperone-mediated 
autophagy pathways 
The data presented here suggest coordinate regulation of these pathways during 
nutritional stress. Several studies have indicated these pathways share 
numerous co-regulators (149, 190, 191). A recent publication has suggested 
competition for HSC70 during MA induction results in suppression of clathrin-
mediated endocytosis (199). Studies addressing the exact mechanisms that 
regulate this coordination of intracellular trafficking pathways are needed. 
Several stresses are known to alter autophagy and endocytic pathways including 
oxidative stress, hypoxia, ER stress, and DNA damage (79-89). Studies 
assessing whether upregulation of MA disrupts endocytosis with different cellular 
stresses could be informative as to whether this is an intrinsic property of these 
pathways. This is of interest as several pathogens are known to regulate MA, yet 
whether this regulation affects other pathways such as endocytosis or 
phagocytosis has not been addressed (172, 206, 207). Furthermore, there are 
several pharmaceuticals that modulate MA used as cancer therapies. If these 
drugs also alter other trafficking pathways within immune cells this could further 
affect the ability of the immune system to recognize and develop long-lived 
responses to eliminate cancer cells (208). 
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Regulation of HSC70  
While total HSC70 protein levels remained unaltered by serum deprivation, the 
availability of HSC70 to perform critical functions in endocytosis and CMA was 
severely compromised in this analysis. While HSC70 is responsible for 
maintaining basal levels of several cellular pathways, the exact role or 
mechanisms HSC70 plays in these pathways remains unknown. HSC70 is bound 
by several co-factors and some studies have suggested these co-factors 
influence the fate of HSC70 bound client proteins (113, 119, 120). For example, 
studies have suggested when bound by the BAG-1 co-factor, HSC70 and its 
client protein are guided to the proteasome. Whereas when bound by BAG-3, 
HSC70 and its client protein are guided to the selective MA pathway (95, 116, 
117). Studies have also linked BAG-1 to the CMA pathway and BAG-3 to the 
ubiquitin proteasome pathway (98, 209). It appears a single co-factor is not 
sufficient to dictate the fate of HSC70 and its associated client proteins. 
However, as HSC70 is bound to several co-factors at any given time, it could be 
the exact composition of co-factors bound to HSC70 that regulates which 
pathway is taken. Furthermore, it is also possible that other factors play a role in 
deciding the fate of HSC70 bound client proteins. Client proteins can be 
ubiquitinated as well as phosphorylated. These post-translational modifications 
may help guide HSC70 complexed with its clients. Studies addressing these 
questions are needed to fully understand the mechanisms by which HSC70 can 
affect cellular trafficking pathways.   
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Furthermore, studies addressing the role of HSC70 in regulating MA are needed. 
The current study results are the first to the indicate availability of HSC70 may 
regulate induction of MA during nutrient stress. Whether HSC70 regulates MA 
during other types of cellular stress has not been studied. Interestingly, though 
HSC70 does not contain a secretory signal sequence, studies have shown it can 
be secreted from cells and that secretion of HSC70 is enhanced during serum 
deprivation (210, 211). This suggests HSC70 may regulate MA via two distinct 
pathways; a direct path in the cytoplasm or by its secretion and affects in the 
extracellular milieu. Furthermore, the mechanisms that limit accessibility of 
HSC70 during nutrient stress have not been established. It is possible that 
autophagosomes associate preferentially with HSC70 complexed with ADP vs. 
ATP. Thus cellular ATP levels could reflect macronutrient availability. As the 
content of cellular ATP drops during serum deprivation (212), this may limit the 
abundance of HSC70:ATP complexes. Binding of ADP will alter HSC70 
chaperoning function; however, whether this specifically affects the role of 
HSC70 in cellular trafficking pathways has not been established. Furthermore, 
the effect of serum deprivation on HSC70 co-factors is not known. Thus, 
investigations into the connections between cellular energy (ATP to ADP ratios) 
as well as changes in the levels of HSC70 co-chaperones, would be informative 
in providing more molecular insights into how cells respond to macronutrient 
deprivation.  
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Conclusion 
In summary, connections between cellular endocytic and autophagic pathways 
shape MHC class II Ag presentation to influence adaptive immunity. Here, 
macronutrient availability was shown to upregulate MA flux and impair the ability 
of B cells to internalize cell surface Ag receptors, impacting MHC class II Ag 
presentation. These data revealed HSC70 as a connection between routes of Ag 
delivery suggesting coordinated regulation of these pathways may influence 
MHC class II epitope selection. Together these findings reveal a previously 
unknown connection between macronutrient sensing and Ag trafficking within 
lymphocytes, which may contribute to impaired adaptive immune response in 
protein malnourished individuals. 
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